MLL	O
and	O
CALM	B-DNA
are	O
fused	O
to	O
AF10	B-DNA
in	O
morphologically	O
distinct	O
subsets	O
of	O
acute	O
leukemia	O
with	O
translocation	B-DNA
t	I-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
:	O
both	O
rearrangements	O
are	O
associated	O
with	O
a	O
poor	O
prognosis	O
.	O

The	O
translocation	B-DNA
t	I-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
(	I-DNA
p13	I-DNA
;	I-DNA
q14	I-DNA
)	I-DNA
has	O
been	O
observed	O
in	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
as	O
well	O
as	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
.	O

A	O
recent	O
study	O
showed	O
a	O
MLL/AF10	B-DNA
fusion	I-DNA
in	O
all	O
cases	O
of	O
AML	O
with	O
t	B-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
and	O
various	O
breakpoints	O
on	O
chromosome	B-DNA
11	I-DNA
ranging	O
from	O
q13	B-DNA
to	O
q23	B-DNA
.	O

We	O
recently	O
cloned	O
CALM	B-DNA
(	O
Clathrin	B-DNA
Assembly	I-DNA
Lymphoid	I-DNA
Myeloid	I-DNA
leukemia	I-DNA
gene	I-DNA
)	O
,	O
the	O
fusion	O
partner	O
of	O
AF10	B-DNA
at	O
11q14	B-DNA
in	O
the	O
monocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
U937	I-cell_line
.	O

To	O
further	O
define	O
the	O
role	O
of	O
these	O
genes	O
in	O
acute	O
leukemias	O
,	O
10	O
cases	O
(	O
9	O
AML	O
and	O
1	O
ALL	O
)	O
with	O
cytogenetically	O
proven	O
t	B-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
(	I-DNA
p12-14	I-DNA
;	I-DNA
q13-21	I-DNA
)	I-DNA
and	O
well-characterized	O
morphology	O
,	O
immunophenotype	O
,	O
and	O
clinical	O
course	O
were	O
analyzed	O
.	O

Interphase	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
was	O
performed	O
with	O
2	O
YACs	B-DNA
flanking	O
the	O
CALM	B-DNA
region	I-DNA
,	O
a	O
YAC	B-DNA
contig	I-DNA
of	O
the	O
MLL	B-DNA
region	I-DNA
,	O
and	O
a	O
YAC	B-DNA
spanning	O
the	O
AF10	B-DNA
breakpoint	O
.	O

Rearrangement	O
of	O
at	O
least	O
one	O
of	O
these	O
genes	O
was	O
detected	O
in	O
all	O
cases	O
with	O
balanced	O
t	B-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
.	O

In	O
4	O
cases	O
,	O
including	O
3	O
AML	O
with	O
immature	O
morphology	O
(	O
1	O
AML-M0	O
and	O
2	O
AML-M1	O
)	O
and	O
1	O
ALL	O
,	O
the	O
signals	O
of	O
the	O
CALM	B-DNA
YACS	I-DNA
were	O
separated	O
in	O
interphase	O
cells	O
,	O
indicating	O
a	O
translocation	O
breakpoint	O
within	O
the	O
CALM	B-DNA
region	I-DNA
.	O

MLL	O
was	O
rearranged	O
in	O
3	O
AML	O
with	O
myelomonocytic	O
differentiation	O
(	O
2	O
AML-M2	O
and	O
1	O
AML-M5	O
)	O
,	O
including	O
1	O
secondary	O
AML	O
.	O

In	O
all	O
3	O
cases	O
,	O
a	O
characteristic	O
immunophenotype	O
was	O
identified	O
(	O
CD4+	B-protein
,	O
CD13	B-protein
-	O
,	O
CD33+	O
,	O
CD65s+	O
)	O
.	O

AF-10	O
was	O
involved	O
in	O
5	O
of	O
6	O
evaluable	O
cases	O
,	O
including	O
1	O
case	O
without	O
detectable	O
CALM	B-DNA
or	O
MLL	O
rearrangement	O
.	O

In	O
2	O
complex	O
translocations	O
,	O
none	O
of	O
the	O
three	O
genes	O
was	O
rearranged	O
.	O

All	O
cases	O
had	O
a	O
remarkably	O
poor	O
prognosis	O
,	O
with	O
a	O
mean	O
survival	O
of	O
9.6	O
+/-	O
6.6	O
months	O
.	O

For	O
the	O
7	O
AML	O
cases	O
that	O
were	O
uniformly	O
treated	O
according	O
to	O
the	O
AMLCG86/92	O
protocols	O
,	O
disease-free	O
and	O
overall	O
survival	O
was	O
significantly	O
worse	O
than	O
for	O
the	O
overall	O
study	O
group	O
(	O
P	O
=	O
.03	O
and	O
P	O
=	O
.01	O
,	O
respectively	O
)	O
.	O

We	O
conclude	O
that	O
the	O
t	B-DNA
(	I-DNA
10	I-DNA
;	I-DNA
11	I-DNA
)	I-DNA
(	I-DNA
p13	I-DNA
;	I-DNA
q14	I-DNA
)	I-DNA
indicates	O
CALM	B-DNA
and	I-DNA
MLL	I-DNA
rearrangements	I-DNA
in	O
morphologically	O
distinct	O
subsets	O
of	O
acute	O
leukemia	O
and	O
may	O
be	O
associated	O
with	O
a	O
poor	O
prognosis	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MLL	NULL
and	NULL
CALM	NULL
Are	NULL
Fused	NULL
to	NULL
AF10	NULL
in	NULL
Morphologically	NULL
Distinct	NULL
Subsets	NULL
of	NULL
Acute	NULL
Leukemia	NULL
With	NULL
Translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
:	NULL
Both	NULL
Rearrangements	NULL
Are	NULL
Associated	NULL
With	NULL
a	NULL
Poor	NULL
Prognosis	NULL
By	NULL
M.H	NULL
.	NULL

Dreyling	NULL
,	NULL
K.	NULL
Schrader	NULL
,	NULL
C.	NULL
Fonatsch	NULL
,	NULL
B.	NULL
Schlegelberger	NULL
,	NULL
D.	NULL
Haase	NULL
,	NULL
C.	NULL
Schoch	NULL
,	NULL
W.-D.	NULL
Ludwig	NULL
,	NULL
H.	NULL
Loffler	NULL
,	NULL
T.	NULL
Blchner	NULL
,	NULL
B.	NULL
Wo√©rmann	NULL
,	NULL
W.	NULL
Hiddemann	NULL
,	NULL
and	NULL
S.K	NULL
.	NULL

Bohlander	NULL
The	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
as	NULL
well	NULL
as	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
showed	NULL
a	NULL
MLL/AFTO	NULL
fusion	NULL
in	NULL
all	NULL
cases	NULL
of	NULL
AML	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
and	NULL
various	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
11	NULL
ranging	NULL
from	NULL
q13	NULL
to	NULL
g23	NULL
.	NULL

We	NULL
recently	NULL
cloned	NULL
CALM	NULL
(	NULL
Clathrin	NULL
Assembly	NULL
Lymphoid	NULL
Myeloid	NULL
leukemia	NULL
gene	NULL
)	NULL
,	NULL
the	NULL
fusion	NULL
partner	NULL
of	NULL
AFTZO	NULL
at	NULL
11q14	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

To	NULL
further	NULL
define	NULL
the	NULL
role	NULL
of	NULL
these	NULL
genes	NULL
in	NULL
acute	NULL
leukemias	NULL
,	NULL
10	NULL
cases	NULL
(	NULL
9	NULL
AML	NULL
and	NULL
1	NULL
ALL	NULL
)	NULL
with	NULL
cytogenetically	NULL
proven	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-14	NULL
;	NULL
q13-21	NULL
)	NULL
and	NULL
well-characterized	NULL
morphology	NULL
,	NULL
immunophenotype	NULL
,	NULL
and	NULL
clinical	NULL
course	NULL
were	NULL
analyzed	NULL
.	NULL

Interphase	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
2	NULL
YACs	NULL
flanking	NULL
the	NULL
CALM	NULL
region	NULL
,	NULL
a	NULL
YAC	NULL
contig	NULL
of	NULL
the	NULL
MLL	NULL
region	NULL
,	NULL
and	NULL
a	NULL
YAC	NULL
spanning	NULL
the	NULL
AFIO	NULL
breakpoint	NULL
.	NULL

Rearrangement	NULL
of	NULL
at	NULL
least	NULL
one	NULL
of	NULL
these	NULL
genes	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
with	NULL
balanced	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

In	NULL
4	NULL
cases	NULL
,	NULL
including	NULL
3	NULL
AML	NULL
with	NULL
immature	NULL
morphology	NULL
(	NULL
1	NULL
AML-MO	NULL
and	NULL
2	NULL
AML-M1	NULL
)	NULL
and	NULL
1	NULL
ALL	NULL
,	NULL
the	NULL
signals	NULL
of	NULL
the	NULL
CALM	NULL
YACS	NULL
were	NULL
ALIGNANT	NULL
TRANSFORMATION	NULL
is	NULL
a	NULL
multistep	NULL
pro	NULL
cess	NULL
that	NULL
involves	NULL
the	NULL
sequential	NULL
alteration	NULL
of	NULL
genes	NULL
regulating	NULL
cell	NULL
growth	NULL
and/or	NULL
differentiation	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
genes	NULL
involved	NULL
in	NULL
leukemogenesis	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
the	NULL
molecular	NULL
analysis	NULL
of	NULL
nonrandom	NULL
chromosome	NULL
abnormalities	NULL
.	NULL

!	NULL

The	NULL
rare	NULL
,	NULL
but	NULL
recurring	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
as	NULL
well	NULL
as	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
.	NULL
``	NULL

A	NULL
recent	NULL
study	NULL
showed	NULL
a	NULL
MLL/AF1O	NULL
fusion	NULL
in	NULL
all	NULL
cases	NULL
of	NULL
AML	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
and	NULL
various	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
11q	NULL
,	NULL
including	NULL
6	NULL
cases	NULL
with	NULL
rearrangement	NULL
of	NULL
chromosomal	NULL
band	NULL
11413	NULL
.	NULL
``	NULL

MLL	NULL
(	NULL
also	NULL
called	NULL
ALL1	NULL
,	NULL
Hirx1	NULL
,	NULL
and	NULL
HRX	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
translocations	NULL
with	NULL
up	NULL
to	NULL
40	NULL
different	NULL
translocation	NULL
partner	NULL
genes	NULL
in	NULL
AML	NULL
as	NULL
well	NULL
as	NULL
acute	NULL
lymphoid	NULL
leukemia	NULL
,	NULL
including	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q23	NULL
)	NULL
in	NULL
AML	NULL
.	NULL

*2	NULL
In	NULL
this	NULL
translocation	NULL
,	NULL
the	NULL
fusion	NULL
partner	NULL
genes	NULL
AF-10	NULL
and	NULL
MLL	NULL
are	NULL
often	NULL
found	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
complex	NULL
rearrangements	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
University	NULL
of	NULL
G6t-tingen	NULL
,	NULL
Gottingen	NULL
,	NULL
Germany	NULL
;	NULL
the	NULL
Institute	NULL
of	NULL
Medical	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Vienna	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
;	NULL
the	NULL
Institute	NULL
of	NULL
Human	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Kiel	NULL
,	NULL
Kiel	NULL
,	NULL
Germany	NULL
;	NULL
the	NULL
Robert-Rossle-Clinic	NULL
,	NULL
Department	NULL
of	NULL
Hematology/Oncology	NULL
and	NULL
Tumor	NULL
Immunology	NULL
,	NULL
Humboldt-University	NULL
of	NULL
Berlin	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
Hospital	NULL
of	NULL
Kiel	NULL
,	NULL
Kiel	NULL
,	NULL
Germany	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
!	NULL

Oncology	NULL
,	NULL
University	NULL
of	NULL
Minster	NULL
,	NULL
Minster	NULL
Germany	NULL
;	NULL
and	NULL
the	NULL
Institute	NULL
of	NULL
Human	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Gottingen	NULL
,	NULL
Gottingen	NULL
,	NULL
Germany	NULL
.	NULL

Submitted	NULL
November	NULL
17	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
February	NULL
3	NULL
,	NULL
1998	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
M.H	NULL
.	NULL

Dreyling	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
University	NULL
of	NULL
G√©ttingen	NULL
,	NULL
Robert	NULL
Koch-Street	NULL
40	NULL
,	NULL
D-37075	NULL
G√©ttingen	NULL
,	NULL
Germany	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

¬©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9112-0038	NULL
$	NULL
3.00/0	NULL
4662	NULL
separated	NULL
in	NULL
interphase	NULL
cells	NULL
,	NULL
indicating	NULL
a	NULL
translocation	NULL
breakpoint	NULL
within	NULL
the	NULL
CALM	NULL
region	NULL
.	NULL

MLL	NULL
was	NULL
rearranged	NULL
in	NULL
3	NULL
AML	NULL
with	NULL
myelomonocytic	NULL
differentiation	NULL
(	NULL
2	NULL
AML-M2	NULL
and	NULL
1	NULL
AML-M5	NULL
)	NULL
,	NULL
including	NULL
1	NULL
secondary	NULL
AML	NULL
.	NULL

In	NULL
all	NULL
3	NULL
cases	NULL
,	NULL
a	NULL
characteristic	NULL
immunophenotype	NULL
was	NULL
identified	NULL
(	NULL
CD4+	NULL
,	NULL
CD13-~	NULL
,	NULL
CD33+t	NULL
,	NULL
CD65st	NULL
)	NULL
.	NULL

AF-10	NULL
was	NULL
involved	NULL
in	NULL
5	NULL
of	NULL
6	NULL
evaluable	NULL
cases	NULL
,	NULL
including	NULL
1	NULL
case	NULL
without	NULL
detectable	NULL
CALM	NULL
or	NULL
MLL	NULL
rearrangement	NULL
.	NULL

In	NULL
2	NULL
complex	NULL
translocations	NULL
,	NULL
none	NULL
of	NULL
the	NULL
three	NULL
genes	NULL
was	NULL
rearranged	NULL
.	NULL

All	NULL
cases	NULL
had	NULL
a	NULL
remarkably	NULL
poor	NULL
prognosis	NULL
,	NULL
with	NULL
a	NULL
mean	NULL
survival	NULL
of	NULL
9.6	NULL
+	NULL
6.6	NULL
months	NULL
.	NULL

For	NULL
the	NULL
7	NULL
AML	NULL
cases	NULL
that	NULL
were	NULL
uniformly	NULL
treated	NULL
according	NULL
to	NULL
the	NULL
AMLCG86/92	NULL
protocols	NULL
,	NULL
disease-free	NULL
and	NULL
overall	NULL
survival	NULL
w	NULL
as	NULL
significantly	NULL
w	NULL
orse	NULL
than	NULL
for	NULL
the	NULL
overall	NULL
study	NULL
group	NULL
(	NULL
P	NULL
=	NULL
.03	NULL
and	NULL
P	NULL
=	NULL
.01	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
indicates	NULL
CALM	NULL
and	NULL
MLL	NULL
rearrangements	NULL
in	NULL
morphologically	NULL
distinct	NULL
subsets	NULL
of	NULL
acute	NULL
leukemia	NULL
and	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
a	NULL
poor	NULL
prognosis	NULL
.	NULL

¬©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

(	NULL
inversions/insertions	NULL
)	NULL
,	NULL
because	NULL
they	NULL
are	NULL
transcribed	NULL
in	NULL
opposite	NULL
direction	NULL
relative	NULL
to	NULL
the	NULL
telomere/centromere	NULL
orientation.¬©	NULL
These	NULL
complex	NULL
rearrangements	NULL
may	NULL
be	NULL
interpreted	NULL
as	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14-21	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
characterization	NULL
of	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
identified	NULL
a	NULL
different	NULL
breakpoint	NULL
on	NULL
chromosome	NULL
11	NULL
,	NULL
involving	NULL
the	NULL
previously	NULL
unknown	NULL
gene	NULL
CALM	NULL
.	NULL
``	NULL

CALM	NULL
has	NULL
a	NULL
very	NULL
high	NULL
homology	NULL
to	NULL
the	NULL
murine	NULL
clathrin	NULL
assembly	NULL
protein	NULL
ap-3	NULL
.	NULL
``	NULL

''	NULL
Interestingly	NULL
,	NULL
both	NULL
translocations	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
have	NULL
the	NULL
same	NULL
fusion	NULL
partner	NULL
gene	NULL
on	NULL
chromosome	NULL
10	NULL
,	NULL
the	NULL
putative	NULL
transcription	NULL
factor	NULL
AFIO	NULL
.	NULL

!	NULL

14	NULL
!	NULL

6	NULL
To	NULL
further	NULL
define	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
three	NULL
genes	NULL
AFIO	NULL
,	NULL
CALM	NULL
,	NULL
and	NULL
MLL	NULL
in	NULL
acute	NULL
leukemias	NULL
,	NULL
we	NULL
analyzed	NULL
10	NULL
cases	NULL
(	NULL
9	NULL
AML	NULL
and	NULL
1	NULL
ALL	NULL
)	NULL
with	NULL
cytogenetically	NULL
proven	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-14	NULL
;	NULL
q13-21	NULL
)	NULL
and	NULL
well-characterized	NULL
morphology	NULL
,	NULL
immunophenotype	NULL
,	NULL
and	NULL
clinical	NULL
course	NULL
.	NULL

Only	NULL
cytogenetic	NULL
material	NULL
stored	NULL
in	NULL
fixative	NULL
for	NULL
several	NULL
years	NULL
was	NULL
available	NULL
,	NULL
which	NULL
was	NULL
not	NULL
suitable	NULL
for	NULL
an	NULL
analysis	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
.	NULL

An	NULL
interphase	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
approach	NULL
was	NULL
chosen	NULL
.	NULL
``	NULL

Nonchimeric	NULL
YACs	NULL
from	NULL
the	NULL
genomic	NULL
region	NULL
of	NULL
the	NULL
three	NULL
genes	NULL
were	NULL
used	NULL
.	NULL

A	NULL
translocation	NULL
was	NULL
assumed	NULL
when	NULL
one	NULL
of	NULL
the	NULL
YAC	NULL
signals	NULL
was	NULL
split	NULL
resulting	NULL
in	NULL
three	NULL
hybridization	NULL
signals	NULL
in	NULL
a	NULL
diploid	NULL
interphase	NULL
nucleus	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patient	NULL
samples	NULL
.	NULL

-	NULL
This	NULL
study	NULL
was	NULL
designed	NULL
and	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
updated	NULL
declaration	NULL
of	NULL
Helsinki	NULL
.	NULL

Patient	NULL
material	NULL
was	NULL
collected	NULL
from	NULL
725	NULL
cases	NULL
that	NULL
entered	NULL
the	NULL
studies	NULL
of	NULL
the	NULL
German	NULL
AML	NULL
Cooperative	NULL
Group	NULL
86	NULL
and	NULL
92	NULL
and	NULL
that	NULL
were	NULL
subjected	NULL
to	NULL
cytogenetic	NULL
analysis	NULL
.	NULL
``	NULL

''	NULL
Based	NULL
on	NULL
the	NULL
cytogenetic	NULL
data	NULL
and	NULL
the	NULL
availability	NULL
of	NULL
material	NULL
,	NULL
8	NULL
cases	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-14	NULL
;	NULL
q13-21	NULL
)	NULL
were	NULL
identified	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
1	NULL
adult	NULL
ALL	NULL
(	NULL
no	NULL
.	NULL

10	NULL
)	NULL
and	NULL
1	NULL
infant	NULL
AML	NULL
(	NULL
mo	NULL
.	NULL

6	NULL
)	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
were	NULL
included	NULL
in	NULL
this	NULL
series	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
morphologically	NULL
classified	NULL
according	NULL
to	NULL
the	NULL
French-American-British	NULL
(	NULL
FAB	NULL
)	NULL
criteria	NULL
and	NULL
were	NULL
reviewed	NULL
by	NULL
an	NULL
independent	NULL
reference	NULL
hematologist	NULL
(	NULL
HL	NULL
.	NULL
)	NULL

.	NULL

Immunophenotyping	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
consensus	NULL
protocol	NULL
for	NULL
Blood	NULL
,	NULL
Vol	NULL
91	NULL
,	NULL
No	NULL
12	NULL
(	NULL
June	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
4662-4667	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MLL	NULL
AND	NULL
CALM	NULL
ARE	NULL
FUSED	NULL
TO	NULL
AFIO	NULL
IN	NULL
1	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
4663	NULL
Table	NULL
1	NULL
.	NULL

Characteristics	NULL
of	NULL
Acute	NULL
Leukemias	NULL
With	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
Survival	NULL
Sex/	NULL
(	NULL
mos	NULL
)	NULL
Immunophenctype	NULL
FISH	NULL
Age	NULL
Diag-	NULL
Induction	NULL
Event-	NULL
-	NULL
Over-No	NULL
.	NULL

-	NULL
(	NULL
yr	NULL
)	NULL
Leuko	NULL
nosis	NULL
Therapy	NULL
Resp	NULL
-	NULL
Free	NULL
all	NULL
B-Cell	NULL
T-Cell	NULL
-	NULL
Myeloid	NULL
Other	NULL
Karyotype	NULL
AFIO	NULL
CALM	NULL
|	NULL
MLL	NULL
1	NULL
M/51	NULL
60,800	NULL
AML-	NULL
TAD-HAM	NULL
CR	NULL
14	NULL
15	NULL
CDig-	NULL
CD2	NULL
CDis-	NULL
-	NULL
CD10¬Æ	NULL
_	NULL
46	NULL
,	NULL
X¬•	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
g14	NULL
)	NULL
Split	NULL
-	NULL
N	NULL
Split	NULL
MSA	NULL
CD4+	NULL
CD14-	NULL
-	NULL
CD34-CD7+	NULL
-	NULL
CD15~	NULL
_	NULL
HLA-DR*	NULL
CD3s3+	NULL
-	NULL
TDT-CD6Ss+	NULL
2	NULL
F46	NULL
130,300	NULL
AML-	NULL
TAD-TAD	NULL
CR	NULL
15	NULL
19	NULL
CDiss	NULL
CD2~	NULL
CDiss	NULL
-	NULL
CD10-	NULL
48.	NULL
,	NULL
XX	NULL
,	NULL
+6	NULL
,	NULL
+8	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-13	NULL
;	NULL
_	NULL
ND	NULL
N	NULL
Split	NULL
M2	NULL
CD4+*	NULL
-	NULL
CD14-	NULL
_	NULL
CD34+	NULL
g14-21	NULL
)	NULL
CD7-	NULL
-	NULL
CD15~	NULL
_	NULL
HLA-DR	NULL
CD3s3+	NULL
-	NULL
TDT-CD6Ss+	NULL
3	NULL
-	NULL
F39	NULL
13,800	NULL
sec	NULL
.	NULL

TAD-HAM	NULL
ED	NULL
<	NULL
1	NULL
<	NULL
1	NULL
CD19~	NULL
CD2~	NULL
CDiss	NULL
CD10-~	NULL
45	NULL
,	NULL
X	NULL
,	NULL
-X	NULL
,	NULL
der	NULL
(	NULL
10	NULL
)	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-	NULL
_	NULL
ND	NULL
N	NULL
Split	NULL
AML-	NULL
CD4+*	NULL
-	NULL
CD14-	NULL
-	NULL
CD34-	NULL
13	NULL
;	NULL
q13.1	NULL
)	NULL
inv	NULL
(	NULL
11	NULL
)	NULL
(	NULL
q13.1923.1	NULL
)	NULL
,	NULL
M2	NULL
CD7-	NULL
-	NULL
CD15~	NULL
_	NULL
HLA-DR	NULL
der	NULL
(	NULL
11	NULL
}	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-13	NULL
;	NULL
q13.1	NULL
)	NULL
CD3s3+	NULL
-	NULL
TDT-CD6Ss+	NULL
4	NULL
_	NULL
F/74	NULL
200	NULL
AML-	NULL
TAD-HAM*	NULL
CR	NULL
2	NULL
14	NULL
CDiss	NULL
CD2~	NULL
CDi3s	NULL
-	NULL
CD10~	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
;	NULL
17	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q13	NULL
;	NULL
q23	NULL
)	NULL
ND	NULL
N	NULL
ND	NULL
MS	NULL
CD4+	NULL
CD14-	NULL
_	NULL
CD34+	NULL
CD7-	NULL
-	NULL
CD15~	NULL
_	NULL
HLA-DR	NULL
CD3s+	NULL
-	NULL
TDT¬©	NULL
CD6Ss+	NULL
5	NULL
-	NULL
H37	NULL
4,000	NULL
-	NULL
AML-	NULL
TAD-HAM	NULL
CR	NULL
8	NULL
16	NULL
CD2+	NULL
CDist	NULL
CD10-	NULL
46	NULL
,	NULL
XX	NULL
,	NULL
der	NULL
(	NULL
10	NULL
)	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-13	NULL
;	NULL
_	NULL
N	NULL
N	NULL
N	NULL
M1	NULL
CD4-	NULL
CD14-	NULL
-	NULL
CD34+	NULL
g21	NULL
)	NULL
der	NULL
(	NULL
11	NULL
)	NULL
}	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
;	NULL
11	NULL
;	NULL
16	NULL
)	NULL
CD7-	NULL
-	NULL
CD15+	NULL
-	NULL
HLA-DR	NULL
(	NULL
p12-13	NULL
;	NULL
921	NULL
;	NULL
p14-15	NULL
;	NULL
913-22	NULL
)	NULL
CD33~	NULL
-	NULL
TDT-	NULL
del	NULL
(	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
)	NULL
,	NULL
del	NULL
(	NULL
12	NULL
)	NULL
(	NULL
p11.2	NULL
)	NULL
CD6Ss+	NULL
6	NULL
-	NULL
M/z2	NULL
NA	NULL
AML-	NULL
AML-BFMB7	NULL
_	NULL
NA	NULL
NA	NULL
5	NULL
CDis-	NULL
CD2~	NULL
CDi3s-	NULL
-	NULL
CD10-	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12	NULL
;	NULL
q21	NULL
)	NULL
Split	NULL
-	NULL
N	NULL
N	NULL
MS	NULL
CD4-	NULL
CD14-	NULL
-	NULL
CD34-CD7-	NULL
-	NULL
CD15+	NULL
-	NULL
HLA-DR*	NULL
CD3s3+	NULL
-	NULL
TDT-CD6Ss+	NULL
7	NULL
Mg	NULL
1,300	NULL
sec	NULL
.	NULL

TAD-HAM	NULL
ED	NULL
1	NULL
1	NULL
CDi9-	NULL
CD2-	NULL
CD13	NULL
}	NULL
CD10-	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
Split	NULL
-	NULL
Split	NULL
_	NULL
N	NULL
AML-	NULL
CD4~	NULL
CD14-	NULL
-	NULL
CD34+	NULL
M1	NULL
CD7	NULL
#	NULL
¬Æ	NULL
-	NULL
CD15~	NULL
_	NULL
HLA-DR	NULL
CD3s-	NULL
-	NULL
TDT-CD65s-	NULL
M/A7	NULL
20,000	NULL
AML-	NULL
TALL	NULL
ED	NULL
3	NULL
3	NULL
CDi9-	NULL
CD3	NULL
CD1i3t	NULL
ND	NULL
48	NULL
,	NULL
XY	NULL
,	NULL
+3	NULL
,	NULL
add	NULL
(	NULL
7	NULL
)	NULL
(	NULL
q33-35	NULL
)	NULL
,	NULL
Split	NULL
-	NULL
Split	NULL
_	NULL
N	NULL
Mo	NULL
CD33+	NULL
der	NULL
(	NULL
9	NULL
)	NULL
,	NULL
der	NULL
(	NULL
9	NULL
)	NULL
,	NULL
+der	NULL
(	NULL
9	NULL
)	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
g21	NULL
)	NULL
,	NULL
der	NULL
(	NULL
12	NULL
)	NULL
t	NULL
(	NULL
12	NULL
;	NULL
18	NULL
)	NULL
(	NULL
p11	NULL
;	NULL
q11	NULL
)	NULL
,	NULL
-18	NULL
,	NULL
+mar	NULL
9	NULL
-	NULL
F/21	NULL
60,800	NULL
AML-	NULL
TAD-HAM	NULL
CR	NULL
7	NULL
11	NULL
ND	NULL
_	NULL
ND	NULL
ND	NULL
ND	NULL
47	NULL
,	NULL
XX	NULL
,	NULL
+19	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13-14	NULL
;	NULL
Split	NULL
-	NULL
Split	NULL
_	NULL
N	NULL
M1	NULL
g14-21	NULL
)	NULL
10	NULL
_	NULL
M/31	NULL
NA	NULL
T-ALL	NULL
__	NULL
CHOEP	NULL
NA	NULL
7	NULL
11	NULL
CD22	NULL
CD1+*	NULL
CDife	NULL
:	NULL
CD10*	NULL
46	NULL
,	NULL
XY	NULL
,	NULL
del	NULL
(	NULL
7	NULL
)	NULL
(	NULL
q34-435	NULL
)	NULL
,	NULL
ND	NULL
Split	NULL
_	NULL
N	NULL
CD3+	NULL
HLA-DR-	NULL
i	NULL
(	NULL
9	NULL
)	NULL
(	NULL
q10	NULL
)	NULL
,	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p124	NULL
;	NULL
q14	NULL
)	NULL
,	NULL
CD4+	NULL
der	NULL
(	NULL
17	NULL
)	NULL
t	NULL
(	NULL
1	NULL
;	NULL
17	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
p11	NULL
)	NULL
CD5	NULL
Clinical	NULL
,	NULL
immunophenotypic	NULL
,	NULL
and	NULL
cytogenetic	NULL
characteristics	NULL
and	NULL
FISH	NULL
results	NULL
of	NULL
acute	NULL
leukemias	NULL
(	NULL
9	NULL
AML	NULL
and	NULL
1	NULL
ALL	NULL
)	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
Leuko	NULL
,	NULL
leukocytes	NULL
per	NULL
microliter	NULL
at	NULL
presentation	NULL
;	NULL
Resp	NULL
,	NULL
response	NULL
;	NULL
CR	NULL
,	NULL
complete	NULL
response	NULL
;	NULL
ED	NULL
,	NULL
early	NULL
death	NULL
;	NULL
NA	NULL
,	NULL
not	NULL
available	NULL
;	NULL
(	NULL
+	NULL
)	NULL
,	NULL
weakly	NULL
positive	NULL
;	NULL
N	NULL
,	NULL
not	NULL
split	NULL
;	NULL
ND	NULL
,	NULL
not	NULL
done/evaluable	NULL
(	NULL
no	NULL
material	NULL
left	NULL
for	NULL
patients	NULL
no	NULL
.	NULL

4	NULL
and	NULL
10	NULL
;	NULL
poor	NULL
sample	NULL
quality	NULL
for	NULL
patients	NULL
no	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
;	NULL
ALL-BFM87	NULL
,	NULL
com	NULL
bined	NULL
chemotherapy	NULL
following	NULL
the	NULL
BFM87	NULL
protocol*	NULL
``	NULL
;	NULL
T-ALL	NULL
,	NULL
intensified	NULL
combined	NULL
chemotherapy	NULL
for	NULL
adult	NULL
T-cell	NULL
lymphoblastic	NULL
leukemia	NULL
;	NULL
CHOEP	NULL
,	NULL
combined	NULL
chemotherapy	NULL
(	NULL
Cyclophospham	NULL
ide/Adriamycin/	NULL
Vincristin/Etoposide/Prednisolon	NULL
}	NULL
)	NULL
.	NULL

*	NULL
Reduced	NULL
dose	NULL
.	NULL

flow	NULL
cytometric	NULL
immunophenotyping	NULL
of	NULL
hematopoietic	NULL
malignan-cies	NULL
.	NULL

``	NULL
``	NULL
2	NULL
``	NULL
Clinical	NULL
data	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
AMLCG	NULL
study	NULL
center	NULL
or	NULL
directly	NULL
from	NULL
the	NULL
patients	NULL
'	NULL
physicians	NULL
(	NULL
patients	NULL
no	NULL
.	NULL

6	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Patients	NULL
no	NULL
.	NULL

3	NULL
and	NULL
7	NULL
had	NULL
been	NULL
previously	NULL
treated	NULL
for	NULL
malignant	NULL
T-cell	NULL
lymphoma	NULL
and	NULL
were	NULL
in	NULL
complete	NULL
remission	NULL
.	NULL

All	NULL
AML	NULL
patients	NULL
received	NULL
a	NULL
uniform	NULL
chemotherapy	NULL
according	NULL
to	NULL
the	NULL
AMLCG86/92	NULL
protocols	NULL
comprising	NULL
double	NULL
induction	NULL
,	NULL
followed	NULL
by	NULL
intensive	NULL
consolidation	NULL
and	NULL
3	NULL
years	NULL
of	NULL
monthly	NULL
maintenance	NULL
therapy	NULL
.	NULL
``	NULL

''	NULL
Patient	NULL
no	NULL
.	NULL

6	NULL
(	NULL
pediatric	NULL
patient	NULL
)	NULL
and	NULL
patient	NULL
no	NULL
.	NULL

8	NULL
(	NULL
initially	NULL
misclassified	NULL
as	NULL
ALL	NULL
)	NULL
were	NULL
treated	NULL
differently	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Mononuclear	NULL
cells	NULL
of	NULL
patient	NULL
samples	NULL
were	NULL
grown	NULL
in	NULL
short-term	NULL
culture	NULL
or	NULL
processed	NULL
directly	NULL
,	NULL
harvested	NULL
using	NULL
standard	NULL
cytogenetic	NULL
techniques	NULL
,	NULL
and	NULL
stored	NULL
in	NULL
Carnoy	NULL
's	NULL
solution	NULL
until	NULL
final	NULL
analysis	NULL
,	NULL
as	NULL
previously	NULL
published	NULL
.	NULL
``	NULL

FISH	NULL
probes	NULL
.	NULL

-	NULL
YAC-derived	NULL
FISH	NULL
probes	NULL
were	NULL
generated	NULL
either	NULL
by	NULL
a	NULL
sequence-independent	NULL
amplification	NULL
technique	NULL
or	NULL
nick	NULL
translation	NULL
(	NULL
MLL	NULL
YACs	NULL
)	NULL
.232	NULL
For	NULL
AFIO	NULL
,	NULL
a	NULL
YAC	NULL
(	NULL
80763	NULL
,	NULL
1,050	NULL
kb	NULL
)	NULL
from	NULL
the	NULL
Centre	NULL
d'Etude	NULL
Polymorphisme	NULL
Humain	NULL
(	NULL
CEPH	NULL
)	NULL
library	NULL
had	NULL
been	NULL
previously	NULL
identified	NULL
that	NULL
spans	NULL
the	NULL
breakpoint	NULL
region	NULL
on	NULL
10p	NULL
and	NULL
reliably	NULL
detects	NULL
the	NULL
breakpoint	NULL
in	NULL
U937	NULL
.	NULL

!	NULL

+	NULL
For	NULL
MLL	NULL
,	NULL
we	NULL
used	NULL
a	NULL
pool	NULL
of	NULL
two	NULL
YACs	NULL
(	NULL
785c6	NULL
and	NULL
856b9	NULL
)	NULL
that	NULL
span	NULL
the	NULL
MLL	NULL
gene	NULL
and	NULL
approximately	NULL
1.0	NULL
mega-bp	NULL
of	NULL
distally	NULL
flanking	NULL
sequences	NULL
,	NULL
because	NULL
11g23	NULL
translocations	NULL
are	NULL
often	NULL
associated	NULL
with	NULL
interstitial	NULL
deletions	NULL
.	NULL
'	NULL

''	NULL
525	NULL
For	NULL
CALM	NULL
,	NULL
the	NULL
Mega-YAC	NULL
Library	NULL
from	NULL
CEPH	NULL
was	NULL
screened	NULL
with	NULL
the	NULL
previously	NULL
reported	NULL
CALM	NULL
primers	NULL
NG.T45	NULL
and	NULL
NG.B362	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
5	NULL
flanking	NULL
YACs	NULL
of	NULL
the	NULL
region	NULL
were	NULL
identified	NULL
using	NULL
the	NULL
Whitehead	NULL
web	NULL
pages	NULL
(	NULL
www.genome.wi.mit.edu	NULL
)	NULL
.2	NULL
``	NULL
``	NULL
A	NULL
total	NULL
of	NULL
9	NULL
YACs	NULL
were	NULL
evaluated	NULL
by	NULL
FISH	NULL
for	NULL
chimerism	NULL
(	NULL
hybridization	NULL
with	NULL
normal	NULL
peripheral	NULL
blood	NULL
cells	NULL
)	NULL
and	NULL
were	NULL
mapped	NULL
relative	NULL
to	NULL
the	NULL
CALM	NULL
breakpoint	NULL
(	NULL
hybridization	NULL
with	NULL
U937	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
intensity	NULL
of	NULL
hybridization	NULL
signal	NULL
,	NULL
2	NULL
YACs	NULL
(	NULL
proximal	NULL
785c1	NULL
,	NULL
1,390	NULL
kb	NULL
,	NULL
and	NULL
distal	NULL
914D9	NULL
,	NULL
1,190	NULL
kb	NULL
)	NULL
were	NULL
chosen	NULL
for	NULL
interphase	NULL
analysis	NULL
.	NULL

From	NULL
4664	NULL
Hybridization	NULL
.	NULL

Dual-color	NULL
FISH	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
two	NULL
YAC-derived	NULL
probes	NULL
of	NULL
the	NULL
CALM	NULL
region	NULL
as	NULL
well	NULL
as	NULL
the	NULL
AFIO	NULL
YAC	NULL
or	NULL
the	NULL
MLL	NULL
probe	NULL
and	NULL
the	NULL
corresponding	NULL
centromeric	NULL
probe	NULL
(	NULL
CEP10	NULL
and	NULL
CEP11	NULL
Spectrum	NULL
Orange	NULL
;	NULL
Vysis	NULL
,	NULL
Downers	NULL
Grove	NULL
,	NULL
IL	NULL
)	NULL
to	NULL
exclude	NULL
numerical	NULL
chromosomal	NULL
aberrations	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

FISH	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
the	NULL
hybridization	NULL
solution	NULL
contained	NULL
approximately	NULL
0.1	NULL
ug	NULL
of	NULL
each	NULL
probe	NULL
,	NULL
1	NULL
ug	NULL
human	NULL
Cot1l-DNA	NULL
,	NULL
0.6	NULL
ug	NULL
human	NULL
placental	NULL
DNA	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
salmon	NULL
sperm	NULL
DNA/slide	NULL
in	NULL
a	NULL
10	NULL
uL	NULL
volume	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
either	NULL
directly	NULL
labeled	NULL
with	NULL
Cy-3-dUTP	NULL
(	NULL
Vysis	NULL
)	NULL
or	NULL
biotinylated	NULL
and	NULL
detected	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
avidin	NULL
and	NULL
amplified	NULL
with	NULL
antiavidin-FITC	NULL
(	NULL
16-Bio-dUTP	NULL
[	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Germany	NULL
]	NULL
;	NULL
FITC-avidin	NULL
and	NULL
FITC	NULL
anti-avidin	NULL
[	NULL
Vector	NULL
,	NULL
Burlingame	NULL
,	NULL
CAJ	NULL
)	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
counterstained	NULL
with	NULL
4',6'-diamidino-2-phenylindole	NULL
dihydrochloride	NULL
(	NULL
DAPI	NULL
)	NULL
and	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
fluorescence	NULL
microscope	NULL
(	NULL
Zeiss	NULL
,	NULL
Jena	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

For	NULL
each	NULL
case	NULL
,	NULL
at	NULL
least	NULL
100	NULL
single	NULL
,	NULL
intact	NULL
interphase	NULL
cells	NULL
were	NULL
analyzed	NULL
.	NULL

For	NULL
Fig	NULL
1	NULL
,	NULL
separate	NULL
gray	NULL
scale	NULL
images	NULL
of	NULL
DAPI-stained	NULL
cells	NULL
and	NULL
fluorescence	NULL
signals	NULL
were	NULL
captured	NULL
using	NULL
a	NULL
charge-coupled	NULL
device	NULL
camera	NULL
(	NULL
Xillix	NULL
,	NULL
Richmond	NULL
,	NULL
British	NULL
Columbia	NULL
,	NULL
Canada	NULL
)	NULL
and	NULL
were	NULL
pseudocolored	NULL
and	NULL
merged	NULL
using	NULL
Adobe	NULL
Photoshop	NULL
software	NULL
(	NULL
Adobe	NULL
Systems	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
Survival	NULL
data	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
x	NULL
test	NULL
using	NULL
PC	NULL
Statistik	NULL
software	NULL
(	NULL
Topsoft	NULL
,	NULL
Hannover	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

DREYLING	NULL
ET	NULL
AL	NULL
RESULTS	NULL
Patients	NULL
'	NULL
characteristics	NULL
.	NULL

-	NULL
Our	NULL
study	NULL
group	NULL
included	NULL
1	NULL
adult	NULL
T-ALL	NULL
(	NULL
no	NULL
.	NULL

10	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
1	NULL
infant	NULL
AML	NULL
(	NULL
no	NULL
.	NULL

6	NULL
)	NULL
,	NULL
and	NULL
8	NULL
adult	NULL
AML	NULL
.	NULL

The	NULL
morphology	NULL
of	NULL
the	NULL
myeloid	NULL
leukemias	NULL
were	NULL
classified	NULL
as	NULL
immature	NULL
(	NULL
FAB	NULL
MO	NULL
)	NULL
in	NULL
1	NULL
case	NULL
(	NULL
no	NULL
.	NULL

8	NULL
)	NULL
and	NULL
as	NULL
leukemia	NULL
with	NULL
minimal	NULL
maturation	NULL
(	NULL
FAB	NULL
M1	NULL
)	NULL
in	NULL
3	NULL
cases	NULL
(	NULL
no	NULL
.	NULL

5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Significant	NULL
maturation	NULL
at	NULL
or	NULL
beyond	NULL
the	NULL
promyelocyte	NULL
stage	NULL
(	NULL
FAB	NULL
M2	NULL
)	NULL
was	NULL
diagnosed	NULL
in	NULL
2	NULL
cases	NULL
(	NULL
no	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
monocytic	NULL
differentiation	NULL
(	NULL
FAB	NULL
M35	NULL
)	NULL
in	NULL
3	NULL
cases	NULL
(	NULL
no	NULL
.	NULL

1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Leukocyte	NULL
counts	NULL
at	NULL
presentation	NULL
were	NULL
high	NULL
,	NULL
but	NULL
varied	NULL
significantly	NULL
within	NULL
the	NULL
study	NULL
group	NULL
(	NULL
mean	NULL
,	NULL
23,900/uL	NULL
;	NULL
range	NULL
,	NULL
200	NULL
to	NULL
60,800/uL	NULL
)	NULL
.	NULL

All	NULL
patients	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
were	NULL
rather	NULL
young	NULL
(	NULL
36.7	NULL
+	NULL
19.9	NULL
years	NULL
old	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
gender	NULL
bias	NULL
(	NULL
5	NULL
male	NULL
and	NULL
5	NULL
female	NULL
)	NULL
.	NULL

FISH/cytogenetics	NULL
.	NULL

-	NULL
Rearrangements	NULL
of	NULL
AFIO	NULL
and/or	NULL
either	NULL
CALM	NULL
or	NULL
MLL	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
with	NULL
balanced	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

MLL	NULL
rearrangements	NULL
were	NULL
detected	NULL
in	NULL
3	NULL
of	NULL
8	NULL
cases	NULL
(	NULL
no	NULL
.	NULL

1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
including	NULL
the	NULL
only	NULL
cytogenetically	NULL
identified	NULL
inversion	NULL
11	NULL
.	NULL

CALM	NULL
was	NULL
rearranged	NULL
in	NULL
another	NULL
4	NULL
patients	NULL
(	NULL
no	NULL
.	NULL

7	NULL
through	NULL
10	NULL
)	NULL
with	NULL
balanced	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
through	NULL
C	NULL
)	NULL
Interphase	NULL
FISH	NULL
of	NULL
patient	NULL
no	NULL
.	NULL

1	NULL
(	NULL
AML	NULL
with	NULL
AFTO	NULL
and	NULL
CALM	NULL
rearrangement	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Three	NULL
AF1O0	NULL
signals	NULL
(	NULL
green	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
split	NULL
of	NULL
one	NULL
YAC	NULL
signal	NULL
,	NULL
and	NULL
tw	NULL
o	NULL
centromere	NULL
10	NULL
signals	NULL
(	NULL
red	NULL
)	NULL
are	NULL
detectable	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

In	NULL
(	NULL
B	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
(	NULL
green	NULL
)	NULL
and	NULL
the	NULL
distal	NULL
CALM	NULL
YAC	NULL
(	NULL
red	NULL
)	NULL
are	NULL
separated	NULL
,	NULL
indicating	NULL
a	NULL
breakpoint	NULL
within	NULL
this	NULL
genomic	NULL
region	NULL
.	NULL

Tw	NULL
o	NULL
MLL	NULL
signals	NULL
(	NULL
green	NULL
)	NULL
and	NULL
tw	NULL
o	NULL
centromere	NULL
11	NULL
signals	NULL
(	NULL
red	NULL
)	NULL
suggest	NULL
no	NULL
rearrangement	NULL
of	NULL
the	NULL
MLL	NULL
region	NULL
in	NULL
(	NULL
C	NULL
)	NULL
.	NULL

(	NULL
D	NULL
through	NULL
F	NULL
)	NULL
Interphase	NULL
FISH	NULL
of	NULL
patient	NULL
no	NULL
.	NULL

8	NULL
(	NULL
AML	NULL
with	NULL
AFTO	NULL
and	NULL
MLL	NULL
rearrangement	NULL
)	NULL
.	NULL

Three	NULL
AF-10	NULL
signals	NULL
(	NULL
green	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
split	NULL
of	NULL
one	NULL
YAC	NULL
signal	NULL
,	NULL
and	NULL
two	NULL
centromere	NULL
10	NULL
signals	NULL
(	NULL
red	NULL
)	NULL
are	NULL
detectable	NULL
in	NULL
(	NULL
D	NULL
)	NULL
.	NULL

In	NULL
(	NULL
E	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
(	NULL
green	NULL
)	NULL
and	NULL
the	NULL
distal	NULL
CALM	NULL
YAC	NULL
(	NULL
red	NULL
)	NULL
are	NULL
colocalized	NULL
,	NULL
excluding	NULL
a	NULL
rearrangement	NULL
of	NULL
this	NULL
genomic	NULL
region	NULL
.	NULL

In	NULL
(	NULL
F	NULL
)	NULL
,	NULL
the	NULL
detection	NULL
of	NULL
three	NULL
MLL	NULL
signals	NULL
(	NULL
green	NULL
)	NULL
,	NULL
but	NULL
only	NULL
tw	NULL
o	NULL
centromere	NULL
11	NULL
signals	NULL
(	NULL
red	NULL
)	NULL
indicate	NULL
a	NULL
split	NULL
of	NULL
one	NULL
MLL	NULL
probe	NULL
(	NULL
C	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MLL	NULL
AND	NULL
CALM	NULL
ARE	NULL
FUSED	NULL
TO	NULL
AFIO	NULL
IN	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
All	NULL
5	NULL
cases	NULL
of	NULL
7	NULL
with	NULL
MLL	NULL
or	NULL
CALM	NULL
rearrangements	NULL
,	NULL
which	NULL
were	NULL
evaluable	NULL
,	NULL
had	NULL
a	NULL
rearrangement	NULL
of	NULL
AFIO	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
1	NULL
case	NULL
(	NULL
no	NULL
.	NULL

6	NULL
)	NULL
with	NULL
a	NULL
balanced	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
,	NULL
the	NULL
AFIO	NULL
probe	NULL
was	NULL
split	NULL
,	NULL
indicating	NULL
a	NULL
breakpoint	NULL
within	NULL
this	NULL
region	NULL
,	NULL
but	NULL
no	NULL
MLL	NULL
or	NULL
CALM	NULL
rearrangements	NULL
were	NULL
detected	NULL
.	NULL

No	NULL
rearrangements	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
2	NULL
patients	NULL
with	NULL
complex	NULL
rearrangements	NULL
(	NULL
no	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
for	NULL
case	NULL
no	NULL
.	NULL

4	NULL
,	NULL
cell	NULL
material	NULL
was	NULL
only	NULL
sufficient	NULL
for	NULL
hybridization	NULL
with	NULL
the	NULL
CALM	NULL
probes	NULL
.	NULL

Morphology	NULL
and	NULL
immunophenotype	NULL
.	NULL

-	NULL
All	NULL
cases	NULL
with	NULL
MLL	NULL
rearrangement	NULL
showed	NULL
a	NULL
myeloid	NULL
maturation	NULL
at	NULL
or	NULL
beyond	NULL
the	NULL
promyelocyte	NULL
stage	NULL
or	NULL
a	NULL
monocytic	NULL
morphology	NULL
according	NULL
to	NULL
the	NULL
FAB	NULL
classification	NULL
(	NULL
M2	NULL
or	NULL
M5	NULL
)	NULL
,	NULL
including	NULL
1	NULL
secondary	NULL
AML	NULL
after	NULL
treatment	NULL
for	NULL
high	NULL
malignant	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

!	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
cases	NULL
with	NULL
CALM	NULL
rearrangement	NULL
showed	NULL
a	NULL
rather	NULL
immature	NULL
phenotype	NULL
(	NULL
MO	NULL
or	NULL
M1	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
case	NULL
no	NULL
.	NULL

8	NULL
was	NULL
initially	NULL
misdiagnosed	NULL
as	NULL
ALL	NULL
and	NULL
treated	NULL
accordingly	NULL
.	NULL

A	NULL
CALM	NULL
rearrangement	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
only	NULL
ALL	NULL
in	NULL
this	NULL
series	NULL
.	NULL

The	NULL
morphological	NULL
diagnosis	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
typical	NULL
immunophenotype	NULL
with	NULL
expression	NULL
of	NULL
various	NULL
T-cell	NULL
antigens	NULL
and	NULL
coexpression	NULL
of	NULL
CD10	NULL
,	NULL
but	NULL
absence	NULL
of	NULL
a	NULL
myeloid	NULL
marker	NULL
(	NULL
CD11c	NULL
)	NULL
or	NULL
B-cell	NULL
antigens	NULL
.	NULL

A	NULL
complete	NULL
immunophenotype	NULL
was	NULL
available	NULL
in	NULL
only	NULL
1	NULL
of	NULL
3	NULL
AML	NULL
with	NULL
CALM	NULL
rearrangement	NULL
(	NULL
no	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
undifferentiated	NULL
morphology	NULL
of	NULL
this	NULL
case	NULL
,	NULL
leukemic	NULL
blasts	NULL
expressed	NULL
antigens	NULL
often	NULL
associated	NULL
with	NULL
immature	NULL
morphologic	NULL
subtypes	NULL
(	NULL
ie	NULL
,	NULL
CD7	NULL
and	NULL
CD34	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
panmyeloid	NULL
antigens	NULL
tested	NULL
,	NULL
only	NULL
CD13	NULL
was	NULL
weakly	NULL
expressed	NULL
.	NULL

Additionally	NULL
,	NULL
however	NULL
,	NULL
strong	NULL
positivity	NULL
of	NULL
myeloperoxidase	NULL
was	NULL
found	NULL
.	NULL

All	NULL
3	NULL
cases	NULL
with	NULL
MLL	NULL
rearrangement	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
panmyeloid	NULL
antigens	NULL
CD33	NULL
and	NULL
CD65s	NULL
but	NULL
lacked	NULL
CD13	NULL
and	NULL
CD15	NULL
and	NULL
coexpressed	NULL
CD4	NULL
.	NULL

Expression	NULL
of	NULL
markers	NULL
associated	NULL
with	NULL
immaturity	NULL
varied	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
1	NULL
case	NULL
(	NULL
no	NULL
.	NULL

1	NULL
)	NULL
showed	NULL
coexpression	NULL
of	NULL
CD7	NULL
and	NULL
CD10	NULL
.	NULL

Clinical	NULL
course	NULL
.	NULL

-	NULL
In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
hyper-leukocytosis	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
with	NULL
MLL	NULL
rearrangements	NULL
(	NULL
mean	NULL
,	NULL
35,000/uL	NULL
;	NULL
range	NULL
,	NULL
13,800	NULL
to	NULL
60,800/uL	NULL
)	NULL
.5¬∞	NULL
>	NULL
3	NULL
Leukocyte	NULL
counts	NULL
were	NULL
also	NULL
high	NULL
in	NULL
cases	NULL
with	NULL
CALM	NULL
rearrangements	NULL
(	NULL
mean	NULL
,	NULL
27,400/uL	NULL
;	NULL
range	NULL
,	NULL
1,300	NULL
to	NULL
60,800/uL	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
number	NULL
of	NULL
cases	NULL
is	NULL
too	NULL
small	NULL
for	NULL
statistical	NULL
evaluation	NULL
.	NULL

The	NULL
overall	NULL
survival	NULL
of	NULL
the	NULL
total	NULL
group	NULL
was	NULL
remarkably	NULL
poor	NULL
(	NULL
9.6	NULL
+	NULL
6.6	NULL
months	NULL
)	NULL
,	NULL
although	NULL
,	NULL
initially	NULL
,	NULL
5	NULL
of	NULL
8	NULL
evaluable	NULL
patients	NULL
reached	NULL
a	NULL
complete	NULL
remission	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
patients	NULL
with	NULL
MLL	NULL
or	NULL
CALM	NULL
rearrangements	NULL
.	NULL

For	NULL
4665	NULL
the	NULL
7	NULL
patients	NULL
who	NULL
were	NULL
treated	NULL
according	NULL
to	NULL
the	NULL
AMLCG86/92	NULL
protocol	NULL
,	NULL
disease-free	NULL
survival	NULL
and	NULL
overall	NULL
survival	NULL
were	NULL
5	NULL
+	NULL
4.9	NULL
months	NULL
and	NULL
11	NULL
+	NULL
7.2	NULL
months	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
survival	NULL
data	NULL
of	NULL
these	NULL
patients	NULL
were	NULL
significantly	NULL
worse	NULL
than	NULL
for	NULL
the	NULL
overall	NULL
study	NULL
group	NULL
.	NULL

After	NULL
14	NULL
months	NULL
,	NULL
none	NULL
of	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
patients	NULL
but	NULL
40	NULL
%	NULL
of	NULL
the	NULL
overall	NULL
group	NULL
were	NULL
still	NULL
disease-free	NULL
(	NULL
P	NULL
=	NULL
.03	NULL
,	NULL
y	NULL
``	NULL
)	NULL
,	NULL
and	NULL
after	NULL
19	NULL
months	NULL
,	NULL
none	NULL
of	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
patients	NULL
but	NULL
49	NULL
%	NULL
of	NULL
the	NULL
overall	NULL
group	NULL
were	NULL
still	NULL
alive	NULL
(	NULL
P	NULL
=	NULL
.01	NULL
,	NULL
x2	NULL
;	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

!	NULL

8	NULL
DISCUSSION	NULL
The	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
is	NULL
a	NULL
recurring	NULL
chromosomal	NULL
abnormality	NULL
that	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
as	NULL
well	NULL
as	NULL
AML	NULL
.	NULL

*	NULL
``	NULL
On	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
two	NULL
types	NULL
of	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p12-p14	NULL
;	NULL
q13-q21	NULL
)	NULL
have	NULL
been	NULL
characterized	NULL
so	NULL
far	NULL
.	NULL

One	NULL
type	NULL
results	NULL
in	NULL
a	NULL
MLL/AFIO	NULL
fusion	NULL
,	NULL
the	NULL
other	NULL
causes	NULL
a	NULL
CALM/	NULL
AFIO	NULL
fusion	NULL
.	NULL
'	NULL

>	NULL
'*	NULL
We	NULL
performed	NULL
this	NULL
study	NULL
to	NULL
define	NULL
the	NULL
relevance	NULL
of	NULL
MLL	NULL
and	NULL
CALM	NULL
rearrangements	NULL
in	NULL
acute	NULL
leukemia	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q13-21	NULL
)	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
rearrangements	NULL
were	NULL
detected	NULL
with	NULL
similar	NULL
frequency	NULL
in	NULL
cases	NULL
with	NULL
balanced	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

CALM	NULL
was	NULL
rearranged	NULL
in	NULL
AML	NULL
as	NULL
well	NULL
as	NULL
in	NULL
ALL	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
AML	NULL
cases	NULL
with	NULL
CALM	NULL
rearrangement	NULL
had	NULL
a	NULL
rather	NULL
immature	NULL
morphology	NULL
,	NULL
and	NULL
1	NULL
case	NULL
was	NULL
initially	NULL
misdiagnosed	NULL
as	NULL
ALL	NULL
.	NULL

This	NULL
may	NULL
have	NULL
been	NULL
also	NULL
the	NULL
case	NULL
for	NULL
some	NULL
of	NULL
the	NULL
initially	NULL
reported	NULL
ALL	NULL
cases	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
when	NULL
immunophenotyping	NULL
was	NULL
not	NULL
yet	NULL
routinely	NULL
performed	NULL
.	NULL
``	NULL

However	NULL
,	NULL
our	NULL
series	NULL
included	NULL
a	NULL
well-characterized	NULL
lymphoblastic	NULL
leukemia	NULL
as	NULL
well	NULL
as	NULL
myeloid	NULL
leukemias	NULL
,	NULL
suggesting	NULL
that	NULL
CALM	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
early	NULL
progenitor/stem	NULL
cell	NULL
before	NULL
either	NULL
myeloid	NULL
or	NULL
lymphoid	NULL
differentiation	NULL
takes	NULL
place	NULL
.	NULL

CALM	NULL
has	NULL
a	NULL
very	NULL
high	NULL
homology	NULL
to	NULL
ap-3	NULL
,	NULL
a	NULL
murine	NULL
clathrin	NULL
assembly	NULL
protein	NULL
.	NULL
``	NULL

So	NULL
far	NULL
,	NULL
CALM	NULL
is	NULL
the	NULL
only	NULL
protein	NULL
interacting	NULL
with	NULL
clathrin	NULL
that	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
malignant	NULL
transformation	NULL
.	NULL

A	NULL
transactivation	NULL
domain	NULL
that	NULL
was	NULL
recently	NULL
identified	NULL
in	NULL
CALM	NULL
could	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
transformation	NULL
potential	NULL
of	NULL
CALM/AFIO	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
further	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
define	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
CALM/AFIO	NULL
fusion	NULL
contributes	NULL
to	NULL
malignant	NULL
transformation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
rather	NULL
undifferentiated	NULL
morphology	NULL
of	NULL
myeloid	NULL
leukemias	NULL
with	NULL
CALM	NULL
rearrangement	NULL
,	NULL
cases	NULL
with	NULL
MLL	NULL
rearrangement	NULL
showed	NULL
a	NULL
monocytic	NULL
morphology	NULL
or	NULL
a	NULL
myeloid	NULL
maturation	NULL
beyond	NULL
the	NULL
promyelocyte	NULL
stage	NULL
.	NULL

Accordingly	NULL
,	NULL
all	NULL
previously	NULL
reported	NULL
leukemias	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
and	NULL
rearrangement	NULL
of	NULL
MLL	NULL
either	NULL
detected	NULL
by	NULL
FISH	NULL
or	NULL
by	NULL
other	NULL
molecular	NULL
110411	NULL
)	NULL
:	NULL
N=7	NULL
(	NULL
Cens	NULL
.	NULL

0	NULL
)	NULL
AMLCG	NULL
86	NULL
<	NULL
60	NULL
YRS	NULL
:	NULL
N=726	NULL
(	NULL
Cens	NULL
.	NULL

279	NULL
)	NULL
W	NULL
,	NULL
%	NULL
SL	NULL
uy	NULL
ULi	NULL
ayy	NULL
aly	NULL
Lun	NULL
rem	NULL
t	NULL
ug	NULL
soe	NULL
000	NULL
th	NULL
tp	NULL
KUL	NULL
BL	NULL
¬£	NULL
.	NULL

,	NULL
\	NULL
L144	NULL
L1	NULL
100	NULL
;	NULL
75	NULL
S	NULL
3	NULL
PD	NULL
E	NULL
50	NULL
¬©	NULL
o_	NULL
25	NULL
Fig	NULL
2	NULL
.	NULL

Overall	NULL
survival	NULL
in	NULL
AML	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

Kaplan-Meier	NULL
plots	NULL
of	NULL
the	NULL
overall	NULL
survival	NULL
of	NULL
patients	NULL
with	NULL
AML	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
(	NULL
n	NULL
=	NULL
7	NULL
;	NULL
solid	NULL
line	NULL
)	NULL
0	NULL
and	NULL
the	NULL
total	NULL
study	NULL
group	NULL
with	NULL
identical	NULL
treatment	NULL
0	NULL
(	NULL
n	NULL
=	NULL
725	NULL
;	NULL
dotted	NULL
line	NULL
)	NULL
.	NULL

``	NULL
¬Æ	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Years	NULL
since	NULL
Start	NULL
of	NULL
Therapy	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4666	NULL
techniques	NULL
,	NULL
were	NULL
AML-M4	NULL
or	NULL
Similarly	NULL
,	NULL
MLL	NULL
rearrangements	NULL
in	NULL
general	NULL
are	NULL
strongly	NULL
correlated	NULL
with	NULL
monocytic	NULL
or	NULL
myelomonocytic	NULL
phenotypes	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
In	NULL
contrast	NULL
,	NULL
Poirel	NULL
et	NULL
al	NULL
``	NULL
``	NULL
detected	NULL
MLL	NULL
rearrangements	NULL
in	NULL
20	NULL
%	NULL
of	NULL
AML-M1	NULL
.	NULL

However	NULL
,	NULL
these	NULL
translocations	NULL
did	NULL
not	NULL
involve	NULL
chromosome	NULL
10	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
although	NULL
MLL	NULL
rearrangements	NULL
are	NULL
detected	NULL
in	NULL
AML	NULL
as	NULL
well	NULL
as	NULL
ALL	NULL
,	NULL
different	NULL
translocation	NULL
partner	NULL
genes	NULL
are	NULL
usually	NULL
involved	NULL
.	NULL
``	NULL

''	NULL
For	NULL
example	NULL
,	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
and	NULL
t	NULL
(	NULL
11	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13.3	NULL
)	NULL
are	NULL
detected	NULL
in	NULL
ALL	NULL
,	NULL
whereas	NULL
t	NULL
(	NULL
6	NULL
;	NULL
11	NULL
)	NULL
,	NULL
t	NULL
(	NULL
9	NULL
;	NULL
11	NULL
)	NULL
,	NULL
and	NULL
t	NULL
(	NULL
11	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
pl3.1	NULL
)	NULL
are	NULL
common	NULL
translocations	NULL
in	NULL
various	NULL
subtypes	NULL
of	NULL
AML	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
the	NULL
results	NULL
of	NULL
Poirel	NULL
et	NULL
al	NULL
``	NULL
``	NULL
that	NULL
included	NULL
t	NULL
(	NULL
6	NULL
;	NULL
11	NULL
)	NULL
,	NULL
t	NULL
(	NULL
9	NULL
;	NULL
11	NULL
)	NULL
,	NULL
and	NULL
an	NULL
uncharacterized	NULL
t	NULL
(	NULL
11	NULL
;	NULL
19	NULL
)	NULL
might	NULL
not	NULL
be	NULL
applicable	NULL
to	NULL
leukemias	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
a	NULL
previously	NULL
published	NULL
series	NULL
of	NULL
AML	NULL
with	NULL
MLL	NULL
rearrangements	NULL
,	NULL
in	NULL
our	NULL
series	NULL
,	NULL
all	NULL
3	NULL
cases	NULL
with	NULL
MLL	NULL
rearrangement	NULL
were	NULL
CD4*	NULL
,	NULL
CD13~	NULL
,	NULL
CD33*	NULL
,	NULL
CD65s*	NULL
.	NULL
``	NULL

''	NULL
The	NULL
latter	NULL
three	NULL
markers	NULL
are	NULL
panmyeloid	NULL
markers	NULL
that	NULL
are	NULL
rather	NULL
broadly	NULL
expressed	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
this	NULL
immunophenotype	NULL
does	NULL
not	NULL
represent	NULL
an	NULL
aberrant	NULL
expression	NULL
of	NULL
different	NULL
lineage-	NULL
or	NULL
maturity-specific	NULL
markers	NULL
as	NULL
detected	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
leuke-mias	NULL
.	NULL
``	NULL

''	NULL
Hence	NULL
,	NULL
we	NULL
do	NULL
not	NULL
consider	NULL
this	NULL
immunophenotype	NULL
as	NULL
leukemia-specific	NULL
for	NULL
MLL	NULL
translocation	NULL
,	NULL
although	NULL
the	NULL
only	NULL
completely	NULL
characterized	NULL
AML	NULL
with	NULL
CALM	NULL
rearrangement	NULL
had	NULL
a	NULL
clearly	NULL
distinct	NULL
immunophenotype	NULL
(	NULL
CD4-	NULL
,	NULL
CD13*	NULL
,	NULL
CD33~	NULL
,	NULL
CD65s-	NULL
)	NULL
.	NULL

AFIO	NULL
is	NULL
the	NULL
first	NULL
fusion	NULL
partner	NULL
of	NULL
MLL	NULL
,	NULL
which	NULL
is	NULL
fused	NULL
to	NULL
another	NULL
gene	NULL
in	NULL
a	NULL
different	NULL
translocation	NULL
,	NULL
emphasizing	NULL
its	NULL
important	NULL
role	NULL
in	NULL
malignant	NULL
transformation	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
AFIO	NULL
functions	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
and	NULL
that	NULL
the	NULL
zinc	NULL
finger	NULL
might	NULL
constitute	NULL
a	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL
'	NULL

>	NULL
'	NULL
``	NULL
Interestingly	NULL
,	NULL
1	NULL
case	NULL
with	NULL
a	NULL
balanced	NULL
translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
no	NULL
.	NULL

6	NULL
)	NULL
showed	NULL
a	NULL
breakpoint	NULL
within	NULL
the	NULL
AFIO	NULL
region	NULL
,	NULL
but	NULL
did	NULL
not	NULL
have	NULL
a	NULL
CALM	NULL
or	NULL
MLL	NULL
rearrangement	NULL
.	NULL

Translocations	NULL
of	NULL
11423	NULL
are	NULL
often	NULL
associated	NULL
with	NULL
distal	NULL
interstitial	NULL
deletions	NULL
that	NULL
would	NULL
make	NULL
it	NULL
difficult	NULL
to	NULL
detect	NULL
the	NULL
translocation	NULL
by	NULL
FISH	NULL
.	NULL

However	NULL
,	NULL
our	NULL
MLL	NULL
probe	NULL
,	NULL
which	NULL
encompasses	NULL
approximately	NULL
1	NULL
mega-bp	NULL
of	NULL
3	NULL
'	NULL
flanking	NULL
sequences	NULL
,	NULL
was	NULL
able	NULL
to	NULL
detect	NULL
these	NULL
kinds	NULL
of	NULL
translocations	NULL
in	NULL
previous	NULL
studies	NULL
.	NULL
``	NULL

''	NULL
Alternatively	NULL
,	NULL
another	NULL
partner	NULL
gene	NULL
on	NULL
chromosome	NULL
11	NULL
may	NULL
be	NULL
involved	NULL
.	NULL

So	NULL
far	NULL
,	NULL
MLL	NULL
rearrangements	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
negative	NULL
prognostic	NULL
factor	NULL
,	NULL
especially	NULL
in	NULL
childhood	NULL
ALL	NULL
.	NULL

For	NULL
AML	NULL
,	NULL
data	NULL
are	NULL
sparse	NULL
and	NULL
contradictory	NULL
.	NULL

In	NULL
a	NULL
series	NULL
of	NULL
pediatric	NULL
AML	NULL
,	NULL
patients	NULL
with	NULL
t	NULL
(	NULL
9	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p22	NULL
;	NULL
q23	NULL
)	NULL
had	NULL
a	NULL
better	NULL
outcome	NULL
,	NULL
whereas	NULL
Lo	NULL
Coco	NULL
et	NULL
al	NULL
``	NULL
identified	NULL
MLL	NULL
rearrangements	NULL
as	NULL
a	NULL
negative	NULL
prognostic	NULL
factor	NULL
in	NULL
ALL	NULL
and	NULL
AML	NULL
.	NULL
``	NULL

In	NULL
infant	NULL
AML	NULL
,	NULL
11q23/MLL	NULL
abnormalities	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
sur-vival	NULL
.	NULL
``	NULL

''	NULL
In	NULL
our	NULL
study	NULL
,	NULL
all	NULL
cases	NULL
with	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
had	NULL
a	NULL
remarkably	NULL
poor	NULL
prognosis	NULL
.	NULL

This	NULL
holds	NULL
up	NULL
for	NULL
the	NULL
subpopulation	NULL
of	NULL
7	NULL
AMLCGS86/92	NULL
patients	NULL
whose	NULL
event-free	NULL
and	NULL
overall	NULL
survival	NULL
was	NULL
significantly	NULL
worse	NULL
than	NULL
the	NULL
survival	NULL
data	NULL
of	NULL
the	NULL
overall	NULL
study	NULL
group	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
cytogenetic/	NULL
molecular	NULL
analysis	NULL
may	NULL
be	NULL
used	NULL
to	NULL
identify	NULL
this	NULL
subgroup	NULL
with	NULL
poor	NULL
prognosis	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
identify	NULL
a	NULL
MLL	NULL
or	NULL
a	NULL
CALM	NULL
rearrangement	NULL
,	NULL
each	NULL
in	NULL
approximately	NULL
half	NULL
of	NULL
the	NULL
leukemias	NULL
with	NULL
a	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
,	NULL
q13-21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
MLL	NULL
or	NULL
CALM	NULL
rearrangements	NULL
were	NULL
found	NULL
in	NULL
leukemias	NULL
with	NULL
different	NULL
morphol-ogy	NULL
.	NULL

MLL	NULL
translocations	NULL
were	NULL
identified	NULL
in	NULL
leukemias	NULL
with	NULL
DREYLING	NULL
ET	NULL
AL	NULL
monocytic	NULL
morphology	NULL
or	NULL
maturation	NULL
beyond	NULL
the	NULL
promyeloid	NULL
stage	NULL
,	NULL
whereas	NULL
CALM	NULL
rearrangements	NULL
were	NULL
detectable	NULL
in	NULL
immature	NULL
leukemias	NULL
as	NULL
well	NULL
as	NULL
ALL	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
characterize	NULL
the	NULL
biological	NULL
characteristics	NULL
of	NULL
these	NULL
molecular	NULL
alterations	NULL
.	NULL

Recently	NULL
,	NULL
Kobayashi	NULL
et	NULL
al*	NULL
'	NULL
reported	NULL
4	NULL
cases	NULL
of	NULL
acute	NULL
leukemia	NULL
with	NULL
CALM	NULL
rearrangements	NULL
that	NULL
were	NULL
studied	NULL
by	NULL
FISH	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cases	NULL
were	NULL
not	NULL
classified	NULL
according	NULL
to	NULL
the	NULL
FAB	NULL
criteria	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
H.	NULL
D√©hner	NULL
for	NULL
generously	NULL
providing	NULL
the	NULL
MLL	NULL
YACs	NULL
and	NULL
C.	NULL
Sauerland	NULL
for	NULL
assistance	NULL
in	NULL
statistical	NULL
analysis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Rowley	NULL
JD	NULL
:	NULL
Molecular	NULL
cytogenetics	NULL
:	NULL
Rosetta	NULL
stone	NULL
for	NULL
understanding	NULL
cancer-Ninth	NULL
G.	NULL
H.	NULL
A.	NULL
Clowes	NULL
memorial	NULL
award	NULL
lecture	NULL
.	NULL

Cancer	NULL
Res	NULL
50:3816	NULL
,	NULL
1990	NULL
2	NULL
.	NULL

Berger	NULL
R	NULL
,	NULL
Flandrian	NULL
G	NULL
,	NULL
Bernheim	NULL
A	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
Vecchione	NULL
D	NULL
,	NULL
Pacot	NULL
A	NULL
,	NULL
Derre	NULL
J	NULL
,	NULL
Daniel	NULL
M-T	NULL
,	NULL
Valensi	NULL
F	NULL
,	NULL
Sigaux	NULL
F	NULL
,	NULL
Ochoa-Nogguera	NULL
ME	NULL
:	NULL
Cytogenetic	NULL
studies	NULL
on	NULL
519	NULL
consecutive	NULL
de	NULL
novo	NULL
acute	NULL
nonlymphocytic	NULL
leukemias	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cytogenet	NULL
29:9	NULL
,	NULL
1987	NULL
3	NULL
.	NULL

Berger	NULL
R	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
Derre	NULL
J	NULL
,	NULL
Vechione	NULL
D	NULL
,	NULL
Chen	NULL
SJ	NULL
:	NULL
Chromosomal	NULL
rearrangement	NULL
on	NULL
chromosome	NULL
11q14-q21	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Leukemia	NULL
3:560	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Heim	NULL
S	NULL
,	NULL
Bekassy	NULL
A	NULL
,	NULL
Garwicz	NULL
S	NULL
,	NULL
Heldrup	NULL
J	NULL
,	NULL
Kristoffersson	NULL
U	NULL
,	NULL
Mandahal	NULL
N	NULL
,	NULL
Wiebe	NULL
T	NULL
,	NULL
Mitelmann	NULL
F	NULL
:	NULL
Bone	NULL
marrow	NULL
karyotypes	NULL
in	NULL
94	NULL
children	NULL
with	NULL
acute	NULL
leukemia	NULL
.	NULL

Eur	NULL
J	NULL
Hematol	NULL
44:227	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Sait	NULL
SNJ	NULL
,	NULL
Dal	NULL
Cin	NULL
P	NULL
,	NULL
Sandberg	NULL
AA	NULL
:	NULL
Recurrent	NULL
involvement	NULL
of	NULL
11q13	NULL
in	NULL
acute	NULL
nonlymphocytic	NULL
leukemia	NULL
.	NULL

Cancer	NULL
Cytogenet	NULL
Cytogenet	NULL
26:351	NULL
,	NULL
1987	NULL
6	NULL
.	NULL

Beverloo	NULL
HB	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
Wijsman	NULL
J	NULL
,	NULL
Lillington	NULL
DM	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
de	NULL
Klein	NULL
A	NULL
,	NULL
van	NULL
Wering	NULL
E	NULL
,	NULL
Welborn	NULL
J	NULL
,	NULL
Young	NULL
BD	NULL
,	NULL
Hagemeijer	NULL
A	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
Breakpoint	NULL
heterogeneity	NULL
in	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
translocation	NULL
in	NULL
AML-MA4/MS	NULL
resulting	NULL
in	NULL
fusion	NULL
of	NULL
AFIO	NULL
and	NULL
MLL	NULL
is	NULL
resolved	NULL
by	NULL
fluorescent	NULL
in	NULL
situ	NULL
hybridization	NULL
analysis	NULL
.	NULL

Cancer	NULL
Res	NULL
55:4220	NULL
,	NULL
1995	NULL
7	NULL
.	NULL

Ziemin-van	NULL
der	NULL
Pool	NULL
S	NULL
,	NULL
McCabe	NULL
NR	NULL
,	NULL
Gill	NULL
HJ	NULL
,	NULL
Espinosa	NULL
R	NULL
,	NULL
Patel	NULL
Y	NULL
,	NULL
Harden	NULL
A	NULL
,	NULL
Rubinelli	NULL
P	NULL
,	NULL
Smith	NULL
SD	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Diaz	NULL
MO	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
gene	NULL
,	NULL
MLL	NULL
,	NULL
that	NULL
spans	NULL
the	NULL
breakpoint	NULL
in	NULL
11423	NULL
translocations	NULL
associated	NULL
with	NULL
human	NULL
leukemias	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10735	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Cimino	NULL
G	NULL
,	NULL
Moir	NULL
DT	NULL
,	NULL
Canaani	NULL
O	NULL
,	NULL
Williams	NULL
K	NULL
,	NULL
Christ	NULL
WM	NULL
,	NULL
Katzav	NULL
S	NULL
,	NULL
Cannizzaro	NULL
L	NULL
,	NULL
Lange	NULL
B	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Canaani	NULL
E	NULL
:	NULL
Cloning	NULL
of	NULL
ALL-1	NULL
,	NULL
the	NULL
locus	NULL
involved	NULL
in	NULL
leukemias	NULL
with	NULL
the	NULL
t	NULL
(	NULL
4	NULL
;	NULL
11	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q23	NULL
)	NULL
,	NULL
1	NULL
(	NULL
9	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p22	NULL
;	NULL
q23	NULL
)	NULL
,	NULL
and	NULL
t	NULL
(	NULL
11	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13	NULL
)	NULL
chromosome	NULL
translocations	NULL
.	NULL

Cancer	NULL
Res	NULL
51:6712	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Djabali	NULL
M	NULL
,	NULL
Selleri	NULL
L	NULL
,	NULL
Parry	NULL
P	NULL
,	NULL
Bower	NULL
M	NULL
,	NULL
Young	NULL
BD	NULL
,	NULL
Evans	NULL
GA	NULL
:	NULL
A	NULL
trithorax-like	NULL
gene	NULL
is	NULL
interrupted	NULL
by	NULL
chromosome	NULL
11423	NULL
translocations	NULL
in	NULL
acute	NULL
leukemias	NULL
.	NULL

Nat	NULL
Genet	NULL
2:113	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Tkachuk	NULL
DC	NULL
,	NULL
Kohler	NULL
S	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Involvement	NULL
of	NULL
a	NULL
homolog	NULL
of	NULL
Drosophila	NULL
trithorax	NULL
by	NULL
11923	NULL
chromosomal	NULL
translocations	NULL
in	NULL
acute	NULL
leukemias	NULL
.	NULL

Cell	NULL
71:691	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Chaplin	NULL
T	NULL
,	NULL
Ayton	NULL
P	NULL
,	NULL
Bernard	NULL
OA	NULL
,	NULL
Saha	NULL
V	NULL
,	NULL
Della	NULL
Valle	NULL
V	NULL
,	NULL
Hillion	NULL
J	NULL
,	NULL
Gregorini	NULL
A	NULL
,	NULL
Lillington	NULL
D	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Young	NULL
BD	NULL
:	NULL
A	NULL
novel	NULL
class	NULL
of	NULL
zinc	NULL
finger/leucine	NULL
zipper	NULL
genes	NULL
identified	NULL
from	NULL
the	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
leukemia	NULL
.	NULL

Blood	NULL
85:1435	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Chaplin	NULL
T	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
Beverloo	NULL
HB	NULL
,	NULL
Saha	NULL
V	NULL
,	NULL
Hagemeijer	NULL
A	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Young	NULL
BD	NULL
:	NULL
The	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
M5	NULL
)	NULL
consistently	NULL
fuses	NULL
the	NULL
leucine	NULL
zipper	NULL
motif	NULL
of	NULL
AFIO	NULL
onto	NULL
the	NULL
HRX	NULL
gene	NULL
.	NULL

Blood	NULL
86:2073	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Sundstrom	NULL
C	NULL
,	NULL
Nilsson	NULL
K	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
U-937	NULL
)	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
17:565	NULL
,	NULL
1976	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MLL	NULL
AND	NULL
CALM	NULL
ARE	NULL
FUSED	NULL
TO	NULL
AFIO	NULL
IN	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
14	NULL
.	NULL

Dreyling	NULL
MH	NULL
,	NULL
Martinez-Climent	NULL
JA	NULL
,	NULL
Zheng	NULL
M	NULL
,	NULL
Mao	NULL
J	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Bohlander	NULL
SK	NULL
:	NULL
The	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
results	NULL
in	NULL
the	NULL
fusion	NULL
of	NULL
the	NULL
AFIO	NULL
gene	NULL
and	NULL
CALM	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
AP-3	NULL
clathrin	NULL
assembly	NULL
protein	NULL
family	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:4804	NULL
,	NULL
1996	NULL
15	NULL
.	NULL

Morris	NULL
SA	NULL
,	NULL
Schroder	NULL
S	NULL
,	NULL
Plessmann	NULL
U	NULL
,	NULL
Weber	NULL
K	NULL
,	NULL
Ungewickell	NULL
E	NULL
:	NULL
Clathrin	NULL
assembly	NULL
protein	NULL
AP180	NULL
:	NULL
Primary	NULL
structure	NULL
,	NULL
domain	NULL
organization	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
clathrin	NULL
binding	NULL
site	NULL
.	NULL

EMBO	NULL
J	NULL
12:667	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Saha	NULL
V	NULL
,	NULL
Chaplin	NULL
T	NULL
,	NULL
Gregorini	NULL
A	NULL
,	NULL
Ayton	NULL
P	NULL
,	NULL
Young	NULL
BD	NULL
:	NULL
The	NULL
leukemia-associated-protein	NULL
(	NULL
LAP	NULL
)	NULL
domain	NULL
,	NULL
a	NULL
cysteine-rich	NULL
motif	NULL
,	NULL
is	NULL
present	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
proteins	NULL
including	NULL
MLL	NULL
,	NULL
AF10	NULL
,	NULL
and	NULL
MLLT	NULL
proteins	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:9735	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Fischer	NULL
K	NULL
,	NULL
Scholl	NULL
C	NULL
,	NULL
Salat	NULL
J	NULL
,	NULL
Frohling	NULL
S	NULL
,	NULL
Schlenk	NULL
R	NULL
,	NULL
Bentz	NULL
M	NULL
,	NULL
Stilgenbauer	NULL
S	NULL
,	NULL
Lichter	NULL
P	NULL
,	NULL
Dohner	NULL
H	NULL
:	NULL
Design	NULL
and	NULL
validation	NULL
of	NULL
DNA	NULL
probe	NULL
sets	NULL
for	NULL
a	NULL
comprehensive	NULL
interphase	NULL
cytogenetic	NULL
analysis	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
88:3962	NULL
,	NULL
1996	NULL
18	NULL
.	NULL

Hiddemann	NULL
W	NULL
,	NULL
Heinecke	NULL
A	NULL
,	NULL
Biichner	NULL
T	NULL
:	NULL
Intensified	NULL
therapy	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
:	NULL
Results	NULL
of	NULL
the	NULL
German	NULL
AML	NULL
cooperative	NULL
group	NULL
,	NULL
in	NULL
Biichner	NULL
T	NULL
,	NULL
Hiddemann	NULL
W	NULL
,	NULL
Wirmann	NULL
B	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Haematology	NULL
and	NULL
Blood	NULL
Tranfusion	NULL
,	NULL
vol	NULL
.	NULL

38	NULL
:	NULL
Acute	NULL
Leukemias	NULL
VL	NULL
.	NULL

Berlin	NULL
,	NULL
Germany	NULL
,	NULL
Springer	NULL
,	NULL
1997	NULL
,	NULL
p	NULL
769	NULL
19	NULL
.	NULL

Bennett	NULL
JM	NULL
,	NULL
Catovsky	NULL
C	NULL
,	NULL
Daniel	NULL
MT	NULL
,	NULL
Flandrin	NULL
G	NULL
,	NULL
Galton	NULL
DAG	NULL
,	NULL
Gralnick	NULL
HR	NULL
,	NULL
Sultan	NULL
C	NULL
:	NULL
Proposals	NULL
for	NULL
the	NULL
classification	NULL
of	NULL
the	NULL
acute	NULL
leukemias	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
33:451	NULL
,	NULL
1976	NULL
20	NULL
.	NULL

Creutzig	NULL
U	NULL
,	NULL
Harbott	NULL
J	NULL
,	NULL
Sperling	NULL
C	NULL
,	NULL
Ritter	NULL
J	NULL
,	NULL
Zimmermann	NULL
M	NULL
,	NULL
Loffler	NULL
H	NULL
,	NULL
Richm	NULL
H	NULL
,	NULL
Schellong	NULL
G	NULL
,	NULL
Ludwig	NULL
W-D	NULL
:	NULL
Clinical	NULL
significance	NULL
of	NULL
surface	NULL
antigen	NULL
expression	NULL
in	NULL
children	NULL
with	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
:	NULL
Results	NULL
of	NULL
study	NULL
AML-BFM-87	NULL
.	NULL

Blood	NULL
86:3097	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Rothe	NULL
G	NULL
,	NULL
Schmitz	NULL
G	NULL
,	NULL
Adorf	NULL
D	NULL
,	NULL
Barlage	NULL
S	NULL
,	NULL
Gramatzki	NULL
M	NULL
,	NULL
Hanenberg	NULL
H	NULL
,	NULL
H√©ffkes	NULL
HG	NULL
,	NULL
Janossy	NULL
G	NULL
,	NULL
Kniichel	NULL
R	NULL
,	NULL
Ludwig	NULL
WD	NULL
,	NULL
Nebe	NULL
T	NULL
,	NULL
Nel	NULL
C	NULL
,	NULL
Orfao	NULL
A	NULL
,	NULL
Serke	NULL
S	NULL
,	NULL
Sonnen	NULL
R	NULL
,	NULL
Tichelli	NULL
A	NULL
,	NULL
Wormann	NULL
B	NULL
:	NULL
Consensus	NULL
protocol	NULL
for	NULL
the	NULL
flow	NULL
cytometric	NULL
immunophenotyping	NULL
of	NULL
hematopoietic	NULL
malignancies	NULL
.	NULL

Leukemia	NULL
10:877	NULL
,	NULL
1996	NULL
22	NULL
.	NULL

Stollmann	NULL
B	NULL
,	NULL
Fonatsch	NULL
C	NULL
,	NULL
Havers	NULL
W	NULL
:	NULL
Persistent	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
associated	NULL
with	NULL
monosomy	NULL
7	NULL
or	NULL
chromosome	NULL
3	NULL
abnormality	NULL
in	NULL
childhood	NULL
myeloproliferative	NULL
disorders	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
60:183	NULL
,	NULL
1985	NULL
23	NULL
.	NULL

Bohlander	NULL
SK	NULL
,	NULL
Espinosa	NULL
R	NULL
III	NULL
,	NULL
Fernald	NULL
AA	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Diaz	NULL
M	NULL
:	NULL
Sequence-independent	NULL
amplification	NULL
and	NULL
labeling	NULL
of	NULL
yeast	NULL
artificial	NULL
chromosomes	NULL
for	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Cytogenet	NULL
Cell	NULL
Genet	NULL
65:108	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Rowley	NULL
JD	NULL
,	NULL
Diaz	NULL
MO	NULL
,	NULL
Espinosa	NULL
R	NULL
III	NULL
,	NULL
Patel	NULL
YD	NULL
,	NULL
van	NULL
Melle	NULL
E	NULL
,	NULL
Ziemin	NULL
S	NULL
,	NULL
Taillon-Miller	NULL
P	NULL
,	NULL
Lichter	NULL
P	NULL
,	NULL
Evans	NULL
GA	NULL
,	NULL
Kersey	NULL
JH	NULL
,	NULL
Ward	NULL
DC	NULL
,	NULL
Domer	NULL
PH	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
:	NULL
Mapping	NULL
chromosome	NULL
band	NULL
11423	NULL
in	NULL
human	NULL
acute	NULL
leukemia	NULL
with	NULL
biotinylated	NULL
probes	NULL
:	NULL
Identification	NULL
of	NULL
11923	NULL
translocation	NULL
breakpoints	NULL
with	NULL
a	NULL
yeast	NULL
artificial	NULL
chromosome	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:9358	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Kobayashi	NULL
H	NULL
,	NULL
Espinosa	NULL
RI	NULL
,	NULL
Thirman	NULL
MJ	NULL
,	NULL
Gill	NULL
HJ	NULL
,	NULL
Fernald	NULL
AA	NULL
,	NULL
Diaz	NULL
MO	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Heterogeneity	NULL
of	NULL
breakpoints	NULL
of	NULL
11q23	NULL
rearrangements	NULL
in	NULL
hematologic	NULL
malignancies	NULL
identified	NULL
by	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Blood	NULL
82:547	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Cherif	NULL
D	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
Paulien	NULL
S	NULL
,	NULL
James	NULL
MR	NULL
,	NULL
Le	NULL
Paslier	NULL
D	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
Hunting	NULL
11q23	NULL
deletions	NULL
with	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Leukemia	NULL
8:578	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

Hudson	NULL
T	NULL
,	NULL
Stein	NULL
L	NULL
,	NULL
Gerety	NULL
S	NULL
,	NULL
Ma	NULL
J	NULL
,	NULL
Castle	NULL
A	NULL
,	NULL
Silva	NULL
J	NULL
,	NULL
Slonim	NULL
D	NULL
,	NULL
Baptosa	NULL
R	NULL
,	NULL
Kruglya	NULL
KL	NULL
,	NULL
Xu	NULL
S	NULL
,	NULL
Hu	NULL
X	NULL
,	NULL
Colbert	NULL
A	NULL
,	NULL
Rosenberg	NULL
C	NULL
,	NULL
Reeve-Daly	NULL
MP	NULL
,	NULL
Rozen	NULL
S	NULL
,	NULL
Hui	NULL
L	NULL
,	NULL
Wu	NULL
X	NULL
,	NULL
Vestergaard	NULL
C	NULL
,	NULL
Wilson	NULL
K	NULL
,	NULL
Bae	NULL
J	NULL
,	NULL
Maitra	NULL
S	NULL
,	NULL
Ganiatsas	NULL
S	NULL
,	NULL
Evans	NULL
C	NULL
,	NULL
DeAngelis	NULL
M	NULL
,	NULL
Ingalis	NULL
K	NULL
,	NULL
Nahf	NULL
R	NULL
,	NULL
Horton	NULL
L	NULL
,	NULL
Oskin	NULL
M	NULL
,	NULL
Collymore	NULL
A	NULL
,	NULL
Ye	NULL
W	NULL
,	NULL
Kouyoumjian	NULL
V	NULL
,	NULL
Zernsteva	NULL
J	NULL
,	NULL
Tarn	NULL
J	NULL
,	NULL
Devine	NULL
R	NULL
,	NULL
Courtney	NULL
D	NULL
,	NULL
Renaud	NULL
M	NULL
,	NULL
Nguyen	NULL
H	NULL
,	NULL
O'Connor	NULL
T	NULL
,	NULL
Fizames	NULL
C	NULL
,	NULL
Faure	NULL
S	NULL
,	NULL
Gyapay	NULL
G	NULL
,	NULL
Dib	NULL
C	NULL
,	NULL
Morissette	NULL
J	NULL
,	NULL
Orlin	NULL
J	NULL
,	NULL
Birren	NULL
B	NULL
,	NULL
Goodman	NULL
N	NULL
,	NULL
Weissenbach	NULL
J	NULL
,	NULL
Hawkins	NULL
T	NULL
,	NULL
Foote	NULL
S	NULL
,	NULL
Page	NULL
D	NULL
,	NULL
Lander	NULL
E	NULL
:	NULL
An	NULL
STS-based	NULL
map	NULL
of	NULL
the	NULL
human	NULL
genome	NULL
.	NULL

Science	NULL
270:1945	NULL
,	NULL
1995	NULL
4667	NULL
28	NULL
.	NULL

Dib	NULL
C	NULL
,	NULL
Faure	NULL
S	NULL
,	NULL
Fizames	NULL
C	NULL
,	NULL
Samson	NULL
D	NULL
,	NULL
Drouot	NULL
N	NULL
,	NULL
Vignal	NULL
A	NULL
,	NULL
Millasseau	NULL
P	NULL
,	NULL
Marc	NULL
S	NULL
,	NULL
Hazan	NULL
J	NULL
,	NULL
Seboun	NULL
E	NULL
,	NULL
Lathrop	NULL
M	NULL
,	NULL
Gyapay	NULL
G	NULL
,	NULL
Morisette	NULL
J	NULL
,	NULL
Weissenbach	NULL
J	NULL
:	NULL
A	NULL
comprehensive	NULL
genetic	NULL
map	NULL
of	NULL
the	NULL
human	NULL
genome	NULL
based	NULL
on	NULL
5,264	NULL
microsatellites	NULL
.	NULL

Nature	NULL
380:152	NULL
,	NULL
1996	NULL
29	NULL
.	NULL

Dreyling	NULL
MH	NULL
,	NULL
Bohlander	NULL
SK	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Olopade	NULL
OI	NULL
:	NULL
Refined	NULL
mapping	NULL
of	NULL
genomic	NULL
rearrangements	NULL
involving	NULL
the	NULL
short	NULL
arm	NULL
of	NULL
chromosome	NULL
9	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
other	NULL
hematologi-cal	NULL
malignancies	NULL
.	NULL

Blood	NULL
86:1931	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Sorensen	NULL
PHB	NULL
,	NULL
Chien-Shing	NULL
C	NULL
,	NULL
Smith	NULL
FO	NULL
,	NULL
Arthur	NULL
DC	NULL
,	NULL
Domer	NULL
PH	NULL
,	NULL
Bernstein	NULL
ID	NULL
,	NULL
Korsmeyer	NULL
SJ	NULL
,	NULL
Hammond	NULL
GD	NULL
,	NULL
Kersey	NULL
JH	NULL
:	NULL
Molecular	NULL
rearrangements	NULL
of	NULL
the	NULL
MLL	NULL
gene	NULL
are	NULL
present	NULL
in	NULL
most	NULL
cases	NULL
of	NULL
infant	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
and	NULL
are	NULL
strongly	NULL
correlated	NULL
with	NULL
monocytic	NULL
or	NULL
myelomonocytic	NULL
phenotypes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
93:429	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Pui	NULL
CH	NULL
,	NULL
Ribeiro	NULL
RC	NULL
,	NULL
Campana	NULL
D	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Hancock	NULL
ML	NULL
,	NULL
Behm	NULL
FG	NULL
,	NULL
Sandlund	NULL
JT	NULL
,	NULL
Rivera	NULL
GK	NULL
,	NULL
Evans	NULL
WE	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Krance	NULL
R	NULL
:	NULL
Prognostic	NULL
factors	NULL
in	NULL
the	NULL
acute	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
leukemias	NULL
of	NULL
infants	NULL
.	NULL

Leukemia	NULL
10:952	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Cimino	NULL
G	NULL
,	NULL
Rapanotti	NULL
MC	NULL
,	NULL
Rivolta	NULL
A	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
D	NULL
'	NULL
Arcangelo	NULL
E	NULL
,	NULL
Rondelli	NULL
R	NULL
,	NULL
Basso	NULL
G	NULL
,	NULL
Barisone	NULL
E	NULL
,	NULL
Rosanda	NULL
C	NULL
,	NULL
Santostasi	NULL
T	NULL
,	NULL
Canaani	NULL
E	NULL
,	NULL
Masera	NULL
G	NULL
,	NULL
Mandelli	NULL
F	NULL
,	NULL
Biondi	NULL
A	NULL
:	NULL
Prognostic	NULL
relevance	NULL
of	NULL
ALL-I	NULL
gene	NULL
rearrangement	NULL
in	NULL
infant	NULL
acute	NULL
leukemias	NULL
.	NULL

Leukemia	NULL
9:391	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Behm	NULL
FG	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Frestedt	NULL
JL	NULL
,	NULL
Liu	NULL
Q	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Downing	NULL
JR	NULL
,	NULL
Rivera	NULL
GK	NULL
,	NULL
Kersey	NULL
JH	NULL
,	NULL
Pui	NULL
CH	NULL
:	NULL
Rearrangement	NULL
of	NULL
the	NULL
MLL	NULL
gene	NULL
confers	NULL
a	NULL
poor	NULL
prognosis	NULL
in	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
,	NULL
regardless	NULL
of	NULL
presenting	NULL
age	NULL
.	NULL

Blood	NULL
87:2870	NULL
,	NULL
1996	NULL
34	NULL
.	NULL

Bohlander	NULL
SK	NULL
,	NULL
Bartels	NULL
S	NULL
:	NULL
Identification	NULL
and	NULL
mapping	NULL
of	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
in	NULL
CALM	NULL
,	NULL
the	NULL
fusion	NULL
partner	NULL
of	NULL
AFIO	NULL
in	NULL
the	NULL
t	NULL
(	NULL
10,11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q14	NULL
)	NULL
found	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Med	NULL
Genet	NULL
9:44	NULL
,	NULL
1997	NULL
35	NULL
.	NULL

Berger	NULL
R	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
Flexor	NULL
M-A	NULL
,	NULL
Leblanc	NULL
T	NULL
:	NULL
Translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
involving	NULL
the	NULL
MLL	NULL
gene	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Importance	NULL
of	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
analysis	NULL
.	NULL

Ann	NULL
Genet	NULL
39:147	NULL
,	NULL
1995	NULL
36	NULL
.	NULL

Thirman	NULL
MJ	NULL
,	NULL
Gill	NULL
HJ	NULL
,	NULL
Burnett	NULL
RC	NULL
,	NULL
Mbangkollo	NULL
D	NULL
,	NULL
McCabe	NULL
NR	NULL
,	NULL
Kobayashi	NULL
H	NULL
,	NULL
Ziemin-van	NULL
der	NULL
Poel	NULL
S	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Morgan	NULL
R	NULL
,	NULL
Sandberg	NULL
AA	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Larson	NULL
RA	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Diaz	NULL
MO	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Rearrangement	NULL
of	NULL
the	NULL
MLL	NULL
gene	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
and	NULL
acute	NULL
myeloid	NULL
leukemias	NULL
with	NULL
11923	NULL
chromosomal	NULL
translocations	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
329:909	NULL
,	NULL
1993	NULL
37	NULL
.	NULL

Poirel	NULL
H	NULL
,	NULL
Rack	NULL
K	NULL
,	NULL
Delabesse	NULL
E	NULL
,	NULL
Radford-Weiss	NULL
I	NULL
,	NULL
Troussard	NULL
X	NULL
,	NULL
Debert	NULL
C	NULL
,	NULL
Leboeuf	NULL
D	NULL
,	NULL
Bastard	NULL
C	NULL
,	NULL
Picard	NULL
F	NULL
,	NULL
Veil-Buzyn	NULL
A	NULL
,	NULL
Flandrin	NULL
G	NULL
,	NULL
Bernard	NULL
O0	NULL
,	NULL
Macintyre	NULL
E	NULL
:	NULL
Incidence	NULL
and	NULL
characterization	NULL
of	NULL
MLL	NULL
gene	NULL
(	NULL
11g23	NULL
)	NULL
rearrangements	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
M1	NULL
and	NULL
M5	NULL
.	NULL

Blood	NULL
87:2496	NULL
,	NULL
1996	NULL
38	NULL
.	NULL

Wormann	NULL
B	NULL
,	NULL
Safford	NULL
M	NULL
,	NULL
Kinemann	NULL
S	NULL
,	NULL
Biichner	NULL
T	NULL
,	NULL
Hiddemann	NULL
W	NULL
,	NULL
Terstappen	NULL
LWMM	NULL
:	NULL
Detection	NULL
of	NULL
aberrant	NULL
antigen	NULL
expression	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
by	NULL
multiparameter	NULL
flow	NULL
cytometry	NULL
.	NULL

Recent	NULL
Results	NULL
Cancer	NULL
Res	NULL
131:185	NULL
,	NULL
1993	NULL
39	NULL
.	NULL

Lo	NULL
Coco	NULL
F	NULL
,	NULL
Mandelli	NULL
F	NULL
,	NULL
Breccia	NULL
M	NULL
,	NULL
Annino	NULL
L	NULL
,	NULL
Guglielmi	NULL
C	NULL
,	NULL
Petti	NULL
MC	NULL
,	NULL
Testi	NULL
AM	NULL
,	NULL
Alimena	NULL
G	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Canaani	NULL
E	NULL
,	NULL
Cimino	NULL
G	NULL
:	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
ALL-	NULL
]	NULL
I	NULL
rearrangements	NULL
at	NULL
chromosome	NULL
11q23	NULL
in	NULL
acute	NULL
leukemia	NULL
.	NULL

Cancer	NULL
Res	NULL
53:3800	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Martinez-Climent	NULL
JA	NULL
,	NULL
Espinosa	NULL
RI	NULL
,	NULL
Thirman	NULL
MJ	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Abnormalities	NULL
of	NULL
chromosome	NULL
band	NULL
1123	NULL
and	NULL
the	NULL
MLL	NULL
gene	NULL
in	NULL
pediatric	NULL
myelomonocytic	NULL
and	NULL
monoblastic	NULL
leukemias	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
t	NULL
(	NULL
9	NULL
;	NULL
11	NULL
)	NULL
as	NULL
an	NULL
indicator	NULL
of	NULL
long	NULL
survival	NULL
.	NULL

J	NULL
Pediatr	NULL
Hematol	NULL
Oncol	NULL
17:277	NULL
,	NULL
1995	NULL
41	NULL
.	NULL

Kobayashi	NULL
H	NULL
,	NULL
Hosoda	NULL
F	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Sakurai	NULL
M	NULL
,	NULL
Imashuku	NULL
S	NULL
,	NULL
Ohki	NULL
M	NULL
,	NULL
Kaneko	NULL
Y	NULL
:	NULL
Hematologic	NULL
malignancies	NULL
with	NULL
the	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q21	NULL
)	NULL
have	NULL
the	NULL
same	NULL
molecular	NULL
event	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
morphologic	NULL
or	NULL
immunologic	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Chromosom	NULL
Cancer	NULL
20:253	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

¬Æ	NULL
blO	NULL
0d	NULL
1998	NULL
91	NULL
:	NULL
4662-4667	NULL
MLL	NULL
and	NULL
CALM	NULL
Are	NULL
Fused	NULL
to	NULL
AF10	NULL
in	NULL
Morphologically	NULL
Distinct	NULL
Subsets	NULL
of	NULL
Acute	NULL
Leukemia	NULL
With	NULL
Translocation	NULL
t	NULL
(	NULL
10	NULL
;	NULL
11	NULL
)	NULL
:	NULL
Both	NULL
Rearrangements	NULL
Are	NULL
Associated	NULL
With	NULL
a	NULL
Poor	NULL
Prognosis	NULL
A	NULL
_	NULL
g	NULL
``	NULL
JO	NULL
430¬∞	NULL
‚Äú	NULL
?	NULL
)	NULL

``	NULL
O19nN	NULL
i	NULL
{	NULL
¬Æ	NULL
M.H	NULL
.	NULL

Dreyling	NULL
,	NULL
K.	NULL
Schrader	NULL
,	NULL
C.	NULL
Fonatsch	NULL
,	NULL
B.	NULL
Schlegelberger	NULL
,	NULL
D.	NULL
Haase	NULL
,	NULL
C.	NULL
Schoch	NULL
,	NULL
W.-D.	NULL
Ludwig	NULL
,	NULL
H.	NULL
Lofflier	NULL
,	NULL
T.	NULL
Buchner	NULL
,	NULL
B.	NULL
Wormann	NULL
,	NULL
W.	NULL
Hiddemann	NULL
and	NULL
S.K	NULL
.	NULL

Bohlander	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/91/12/4662.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

